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ABSTRACT
THE ROLE OF ANTIMICROBIAL COMPOUNDS IN THE LIFE CYCLE OF THE
SYMBIOTIC BACTERIUM, XENORHABDUS NEMATOPHILA

by
Swati Singh

The University of Wisconsin-Milwaukee, 2014
Under the Supervision of Professor Steven A. Forst, Ph.D.

The bacterium Xenorhabdus nematophila maintains a mutualistic relationship with the
entomopathogenic nematode Steinernema carpocapsae and is also pathogenic towards
insect larvae. X. nematophila possesses a large number of gene clusters potentially
involved in antimicrobial production. Several antibiotics, including xenocoumacin (Xcn)
produced at high levels in broth cultures, have been characterized. In this study I
established that during nematode invasion of the insect body cavity (hemocoel) gut
microbiota enter the hemocoel representing potential competitors for X. nematophila. As
infection progressed some transient species, such as Staphylococcus saprophyticus
disappeared early in infection, while other persistent species such as Enterococcus
faecalis proliferated. S. saprophyticus was found to be highly sensitive towards X.
nematophila antibiotics and E. faecalis was more resistant. S. saprophyticus was
eliminated when co-injected with X. nematophila into the insect host, Manduca sexta. In
contrast, E. faecalis proliferated when co-injected with X. nematophila. The induction of
transcripts for cecropin, an insect antimicrobial peptide, by E. faecalis was suppressed by
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the presence of X. nematophila suggesting that E. faecalis proliferation was due in part to
a combination of immune suppression and relatively high antibiotic resistance. Injection
of E. faecalis into M. sexta caused mortality suggesting that E. faecalis may contribute to,
but is not required for, virulence in an insect infected with X. nematophila. The role of
antibiotics in interspecies competition was assessed using various antibiotic-deficient
strains of X. nematophila co-inoculated in LB broth with either S. saprophyticus or E.
faecalis. Antibiotics are produced at high levels in LB broth. During the course of this
study I discovered a new non-ribosomal peptide synthetase (NRPS) cluster (cluster F)
that produced antibiotic activity. The elimination of S. saprophyticus required Xcn but
not compound F. In contrast, elimination of E. faecalis was not dependent on either Xcn
or compound F. When competitions were carried out in a more biologically relevant
medium (Grace’s medium) based on lepidopteran insect hemolymph, both the
competitors grew better than X. nematophila due to lower production of antibiotics in
Grace’s medium and faster growth rate of the competitors. S. saprophyticus was
eliminated when inoculated into growing cultures of either the xcn or F strains but grew
in the presence of a strain (ngrA) completely devoid of antibiotic activity suggesting that
antibiotics other than Xcn and compound F were required to eliminate the competitor. In
contrast, E. faecalis was not eliminated in competition with any of the X. nematophila
strains consistent with its relatively high antibiotic resistance. S. saprophyticus was
eliminated when co-injected into M. sexta with either the xcn or ngrA strain while growth
of E. faecalis was facilitated by co-inoculation with both of the mutant strains. Finally,
when nematodes carrying the ngrA strain were used for natural infection of M. sexta,
nematode reproduction was significantly reduced suggesting that NRPS-derived
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compounds may function as developmental signals. Together, these findings establish the
competitors for X. nematophila and the role of antimicrobials in differential competition
and nematode reproduction.
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Chapter One
Background and Significance: Antimicrobial Compounds and the Life
Cycle of Xenorhabdus nematophila
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1.0 Introduction
Bacteria exist in multispecies populations in which competition for resources and
space drive community dynamics and evolutionary processes. Microbial communities
that associate with animals and plants are widespread in nature. Pathogens that infect
animal hosts confront a dual challenge of competing with other microbes in the
environment and evading or suppressing activated immune responses of the host. In
defensive mutualistic relationships the ability to produce antimicrobials to eliminate
competitors and compounds to suppress the immune response can improve the fitness of
a symbiotic partner. While competition under laboratory conditions has been extensively
studied, much less is known about the competitive interactions in a host organism. The
tripartite symbiosis involving the mutualistic-pathogenic bacterium Xenorhabdus
nematophila, entomopathogenic nematode Steinernema carpocapsae, and susceptible
insect hosts provides an excellent tractable model to study microbial competition and
immune suppression in a natural biological environment.
In the dual-mode life cycle of X. nematophila the bacterium-nematode symbiont
pair initiates infection of the insect host (FIG. 1.1). The bacterium X. nematophila
colonizes a specialized region of the anterior intestine (receptacle) of the non-feeding
juvenile stage of the nematode called the infective juvenile (IJ) that forages in the soil
searching for susceptible insect hosts (1-3). The IJ invades insect larvae through natural
openings such as the mouth or anus, punctures the midgut to enter the hemocoel (body
cavity) and expels X. nematophila from the receptacle via the anus into the hemolymph
where the bacteria transition to their pathogenic stage (2).
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FIG. 1.1. Schematic diagram of the X. nematophila – S. carpocapsae life cycle
highlighting the pathogenic phase
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Once in the hemocoel X. nematophila functions as a pathogen. Part of being a
successful insect pathogen is the ability to suppress the insect innate immune response,
and another is host-killing, brought about by

the insect toxins, cytotoxins, and

hemolysins that Xenorhabdus secretes (4). Following insect death, bioconversion of the
insect cadaver occurs due to exoenzymes produced by X. nematophila and the diverse
antimicrobial compounds that it produces are believed to play a role in protection of the
nutrient resources. The bacteria multiply using the now abundant nutrients and the
nematodes feed on the bacteria and nutrients from the insect cadaver as they develop and
reproduce. After 2-3 rounds of sexual reproduction, when nutrient sources are depleted,
the second juvenile form develops into the specialized pre-IJ stage that is colonized by X.
nematophila. Once colonized, the IJ leaves the cadaver in search of another insect host.
During this pathogenic phase, translocation of gut microbes into the hemocoel
during nematode invasion, coupled with suppression of insect host immune response by
X. nematophila may facilitate the growth of competitors in the insect hemocoel. The
proliferation of gut-derived microbes in the hemocoel could in turn antagonize the
reproduction of S. carpocapsae and suppress the growth of X. nematophila in the
hemolymph. X. nematophila produces a plethora of antimicrobial compounds that are
believed to participate in controlling competitor growth. Among the various
antimicrobials produced by bacteria and fungi, three broad classes have been defined:
small molecule antibiotics, peptide and protein bacteriocins, and contractile phage-tail
bacteriocins. X. nematophila is unique among bacteria in producing antimicrobial
compounds belonging to all three classes. Besides producing numerous small molecule
antimicrobial compounds, X. nematophila produces phage-tail structures called

5

xenorhabdicins that bind to and kill related Xenorhabdus species and strains as well as
the sister taxon Photorhabdus luminescens (5, 6). Xenorhabdicins provide a competitive
advantage when an insect is co-invaded by more than one nematode species (6). X.
nematophila also produces a protein bacteriocin called xenocin that displays broad
antibiotic activity (7).
Although it has been assumed that antimicrobials are involved in interspecies
competition and enhance the proliferation of X. nematophila and development of its
nematode partner, such roles in the host have never been conclusively demonstrated.
Most of the antimicrobial compounds have been studied in in vitro conditions which are
completely different from the bacterium’s actual natural environment. It is also possible
that some of the compounds that exhibit in vitro antibiotic activity may have other
functions in the host environment.

1.1. Challenges faced by X. nematophila in the insect host
1.1.1. Insect immune response
When S. carpocapsae invades the hemocoel microbiota from the insect gut
translocate into the hemocoel and as yet unidentified signals induce pharyngeal pumping
that expels X. nematophila into the hemolymph (2). Foreign microbes in the hemocoel
are recognized by pattern recognition proteins (PRP) such as hemolin, peptidoglycan
recognition protein (PGRP), and immulectins (8). PRPs in the hemolymph bind
conserved microbial-associated molecular pattern (MAMP) motifs on the surfaces of the
foreign microbes. After the appropriate interactions between the PRPs and MAMPs, the
insect innate immune response is activated. An example of a PRP is hemolin that binds
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bacterial surfaces and causes protein complexes to form (9). Once activated, the immune
response of insects consists of both cellular and humoral pathways. The cellular response
involves activation of hemocytes that entrap microbial invaders in cell aggregates
referred to as nodules. Humoral immune responses include stimulation of phospholipase
A2 (PLA2) activity that releases arachidonic acid from membrane phospholipids
resulting in the production of eicosanoids that activate hemocytes and induce expression
of antimicrobial peptides (AMPs) such as cecropin (10, 11). Cecropin is a bacteriainducible antimicrobial peptide that attacks bacterial cell membranes leading to cell lysis
(11). A central response of the innate immune system is the conversion of
prophenoloxidase (ProPO) to the active phenoloxidase (PO) involved in quinone
synthesis and formation of melanin that binds to the microbial cell surface functioning as
an opsonin.
X. nematophila produces several compounds that suppress different components
of the insect innate immune response. For example, the tyrosine-derived cell surface
molecules (rhabduscin) that directly inhibit PO activity (12) and the monoterpenoid
compound benzylideneacetone (13) that inhibits PLA2 activity, reduces AMP synthesis
and blocks PO activity (10, 14, 15). Eight different secondary metabolites, including
benzylideneacetone, that inhibit phenoloxidase and PLA2, were shown to be produced
sequentially in broth cultures suggesting they act cooperatively to inhibit different stages
of the immune response (16).
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1.1.2. Microbial competitors in the infected insect hemolymph
It would be logical for the most encountered competing microorganisms in the
insect hemocoel to be the insect’s own gut microbiota. It has been assumed that microbes
translocate from the insect gut into the hemocoel during nematode invasion. However,
characterization of gut microbiota and especially monitoring its movement into the
hemocoel during infection had not been reported.
Entomopathogenic nematodes have been shown to infect several Orders of
insects, including Lepidoptera, Diptera, Coleoptera, Orthoptera, and Hymenoptera (17,
18). Different host organisms will harbor entirely different consortia of commensal
microorganisms, indeed, variations have even been found among the gut microbiota of
the same type of insects upon varying their diet. The insect gut microbiota represents the
largest reserve of competitors to X. nematophila if they gain access to the insect
hemocoel during a natural infection as the nematode breaches the intestinal barrier.
The model insects that have been most used to study the life cycle of
entomopathogenic nematodes are the three lepidopterans, the tobacco hornworm
(Manduca sexta), the wax worm (Galleria mellonella), and the common cutworm
(Spodoptera littoralis). In Galleria mellonella, Enterococcus sp. were the most dominant
bacteria isolated in three studies (19-21). In another analysis which identified only Gramnegative bacteria, Salmonella, Pasteurella and Xanthomonas were isolated from the gut
of G. mellonella (22). Interestingly, Enteroroccus sp. was also found in the gut of M.
sexta when raised on the diet of tobacco leaves (23). When raised on a standard lab diet
containing antibiotics, the M. sexta gut isolates included predominantly the Grampositive bacteria, Paenibacillus and Bacillus, and the Gram-negative bacterium,
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Methylobacterium.

In contrast, when raised on standard antibiotic-free diet, the

microbiota of M. sexta contained predominantly Gram-positive Staphylococcus and
Pediococcus sp. and no Gram-negative bacteria (24). The microbiota of Spodoptera has
not yet been analyzed. These findings reveal the enormous microbial diversity arising
from the insect gut microbiota, which varies depending on the insects and even among
insects, on the diet used.
Other sources of potential competitors are the non-symbiotic bacteria that might
be carried between the cuticle and outer sheath of the IJs. Yet another type of competitive
interactions that are feasible is competition between different Xenorhabdus species or
between Xenorhabdus and Photorhabdus, both nematode-associated entomopathogens.
This can occur when the insect host is co-invaded by two or more different Steinernema
species carrying different Xenorhabdus species, or Heterorhabditis species that harbor
Photorhabdus. In such cases, the effective antimicrobial defenses would include those
that can target closely-related organisms, and include proteinaceous and phage-tail
bacteriocins.

1.2. Antimicrobial compounds produced by X. nematophila
1.2.1. Small molecule antimicrobials
Most small molecule antimicrobial compounds are usually synthesized by
complex multi-enzyme systems consisting of non-ribosomal peptide synthetases (NRPS)
and/or polyketide synthetases (PKS). NRPSs are modular enzymes composed of one or
more adenylation (A) domains that bind a specific amino acid, a transfer or peptidyl
carrier protein (T/PCP) domain that shuttles the activated amino acid, and the
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condensation (C) domain that accepts the activated amino acid and catalyzes peptide
bond formation (25). Five different classes of compounds synthesized by NRPS or
NRPS-PKS biosynthetic clusters have been characterized to date (TABLE 1). The
compounds have been isolated from X. nematophila cultures grown to stationary phase in
nutrient-rich, complex media. Their activities were tested against indicator laboratory
strains or clinical strains but not against biologically relevant microbial competitors.
Three of the classes (xenocoumacin, xenematide and PAX peptides) have antibacterial
and/or antifungal activity while the activities of the remaining two compound classes
(rhabdopeptide and xenortide) remain unclear (FIG. A.1).
Xenocoumacins, the first antimicrobials isolated from X. nematophila, are watersoluble benzopyran-1-one compounds (26). X. nematophila produces two forms of
xenocoumacin, Xcn1 and Xcn2. These compounds are structurally and
pharmacologically similar to the amicoumacins produced by Bacillus pumilus. Both
Xcn1 and Xcn2 are active against low G+C Gram-positive bacteria and some E. coli
strains but are not active against other Gram-negative bacteria tested. Xcn1 is active
against several fungal species but was inactive towards Candida albicans. Xcn2 does not
display antifungal activity. Structural analysis predicted that leucine and arginine
residues and several acetate units were utilized for synthesis of Xcn1 (26) .
The 14 gene cluster that encodes enzymes required for production of Xcn1 and
Xcn2 and the biosynthetic pathway have been characterized (27, 28). The xcn
biosynthetic cluster contains two NRPS genes (xcnA, xcnK) and three PKS genes (xcnF,
xcnH, xcnL). A mechanism to prevent self-toxicity to X. nematophila from Xcn has also
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TABLE 1. Known antimicrobial compounds produced by X. nematophila

Name
Class
Xenocoumacin Benzopyran

Activity
Antibacterial
Antifungal

NRPS
2

PKS
3

References
McInerney, 1991
Park, 2009
Reimer, 2009

Xenematide

Cyclic
Non-polar

Antibacterial

1

0

Lang, 2008
Crawford, 2011

PAX peptides

Lysine-rich
Antifungal
cyclolipopeptide Antibacterial

3

0

Gualtieri, 2009
Fuchs, 2011

0

Rhabdopeptide Linear
Non-polar

Antiparasitic
Cytotoxic

4

Xenortide

Unknown

-

Di-amino acid
Non-polar

Reimer, 2013
-

Lang, 2008
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been described (27). The penultimate genes in the xcn cluster, xcnM and xcnN, encode
enzymes that are involved in an unusual reaction in which the guanidinium group of
arginine is removed resulting in a cyclic pyrolidine structure forming the less active Xcn2
(28). Prolonged incubation of an xcnM mutant strain resulted in accumulation of Xcn1
and a reduced viability possibly due to self-toxicity from high concentration of Xcn1
(27).
Studies with the wax worm, Galleria mellonella infected with X. nematophila
suggested that Xcn1 and Xcn2 were produced in insecta. Water extracts of macerated G.
mellonella cadavers infected with X. nematophila displayed antibiotic activity against
Gram-positive species while the activity against Gram-negative species was more
variable (29). HPLC analysis identified the presence of Xcn1 and 2 in a ratio of 1:1 in
these extracts. Antibiotic activity was not recovered by extraction of X. nematophilainfected G. mellonella with organic solvents.
Another antibacterial compound produced by X. nematophila is a cyclic
depsipeptide (Thr-Trp-Trp-β-Ala) called xenematide that is active against some Grampositive and Gram-negative bacteria (30). It is produced by a stand-alone NRPS
(XNC1_2713) that contains four adenylation modules (31).
X. nematophila also produces a group of lysine-rich cyclolipopeptides called PAX
(Peptide-Antimicrobials-Xenorhabdus) that have high activity against various human and
plant fungal pathogens, lower activity against Gram-positive bacteria and minimal
activity against Gram-negative bacteria (32). Thirteen different PAX compounds have
been identified to date (33). The biosynthetic cluster that produces the PAX compounds
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consists of three NRPS genes, the first of which contains one adenylation domain while
the second and third NRPS genes contain three adenylation domains each.
Linear, NRPS-derived peptides called rhabdopeptides were recently identified by
an in vivo expression technology (IVET) approach (34). The biosynthetic cluster for
rhabdopeptides consists of three NRPS genes each containing one adenylation domain.
Six different rhabdopeptides were isolated from broth cultures. Interestingly,
rhabdopeptides were active against parasites such as Trypanosoma brucei and T. cruzi
while their activity against bacteria and fungi was not reported. Rhabdopeptides were
produced in G. mellonella infected with X. nematophila reaching optimal levels 10 days
post-injection when the insect bioconversion or nematode reproduction stages are
occurring.
The fifth class of compounds are two dipeptides called xenortides (30).
Xenortides were not active against bacterial and fungal indicator stains tested and did not
possess cytotoxic activity.
Four other NRPS and NRPS-PKS gene clusters have been identified in the
genome of X. nematophila. Three of the clusters contain only NRPS genes. These
include XNC1_2299-30 (two NRPS genes), XNC1_2038-40 (three NRPS genes), and
XNC1_2464-67 (four NRPS genes). In addition, a mixed hybrid cluster containing three
NRPS genes (XNC1_1762-64) and two PKS genes (XNC_ 1756-57) has been identified.
A stand-alone gene, XNC1_2022 (xtpS - NRPS with four adenylation domains), encodes
xenotetrapeptide (35). Other than XNC1_2022, the compounds encoded by these clusters
have not yet been identified.

13

Several small non-polar compounds possessing antibiotic activity but that have
not yet been associated with any genes have been isolated from broth cultures of X.
nematophila (FIG. A.2) (13, 36, 37). Two related indole derived compounds isolated
from stationary phase cultures were active against low G+C Gram-positive bacteria,
members of the Enterobacteriaceae and Pseudomonas sp. Nematophin, a novel indoletype compound, was active against Bacillus and Staphylococcus sp. (38). Finally,
benzylideneacetone that possesses immune suppression activity as described below was
shown to be active against some species of Gram-negative plant pathogens (13). At
present, the modes of action of the numerous antimicrobial compounds produced by X.
nematophila are not known.

1.2.2. Phage-tail bacteriocins and xenocin
Microbial competitors other than those derived from the insect gut can gain access
to the hemocoel when an insect host is co-invaded by different species of
entomopathogenic nematodes. Thus, competition can occur between different species and
strains of Xenorhabdus and Photorhabdus in a host co-infected by their respective
nematode partners (39-41). Small molecule antimicrobial compounds are generally not
active against closely related species. Bacteria can produce phage tail-like structures that
bind to and kill more closely related species. R-type bacteriocins are contractile phage tail
structures that resemble the tail portion of defective bacteriophages. R-type bacteriocins
have been extensively studied in P. aeruginosa where binding to the cell surface of
sensitive related bacteria causes contraction of the tail sheath and the penetration of the
tail tube through the outer membrane resulting in depolarization of the cytoplasmic
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membrane and increased permeability of the cell envelope (42, 43). X. nematophila
produces R-type bacteriocins referred to as xenorhabdicins (5, 6, 44, 45). Xenorhabdicin
was shown to have variable activity against various Xenorhabdus and Photorhabdus
strains, and also demonstrated intraspecies activity (6).
Finally, X. nematophila produces a 64 kDa bacteriocin called xenocin that
possesses endonuclease activity and is induced under Fe3+ depleted conditions that may
exist in the insect hemolymph. Xenocin was shown to be active against gut bacteria
isolated from Helicoverpa amerigera (cotton boll warm) larvae (7) . The xenocinimmunity protein complex is secreted through the flagella secretion system (46). In the
extracellular environment xenocin is believed to dissociate from the immunity protein
and enter target cells where it degrades cellular nucleic acids.

1.3. Diverse functions of small molecule antimicrobial compounds
The overall percentage of the X. nematophila genome dedicated to secondary
metabolism is 7.5% as compared to 4.5% for Streptomyces coelicolor (47). It would
appear that there is a strong selection for secondary metabolites that confer the ability to
effectively compete against a broad spectrum of microbes that X. nematophila may
encounter. However, the antimicrobial compounds were isolated from cultures of X.
nematophila grown in nutrient-rich complex media and tested against laboratory and
clinical strains in in vitro assays. Whether these compounds are produced in insects at
sufficient levels to suppress growth of potential competitors remains to be determined. It
is possible that several of the compounds play a role in immune suppression, nematode
development, biofilm formation or other processes yet to be identified.
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The most intensely studied antimicrobials are the small molecule antibiotics that
have been exploited for their usefulness as therapeutics and additives in animal feed.
These secondary metabolites are usually most active against distantly related species but
may also be active against more closely related species and strains. Antibiotic production
has been studied mostly under laboratory culture conditions in which antibiotics can
reach high levels. Furthermore, the levels needed for an antimicrobial effect may be
higher than the concentration of compound produced under natural biological conditions
(48-52) Thus, compounds characterized as an antimicrobial under assay conditions may
in fact have other functions, such as signaling molecules, in a natural biological
environment.
A large number of antimicrobial compounds are derived from Streptomyces
species. A well studied example of a role for antimicrobial compounds in nature is a
Streptomyces species (S4) involved in the mutualism between leaf-cutting attine ants and
fungus cultivated by them for food (53). The fungal garden can be invaded by a coevolved fungal pathogen, Escovopsis sp. Streptomyces S4 colonizes a specialized
structure on the cuticle of the ant and helps to protect the food source. In broth cultures
Streptomyces S4 produces two antifungal compounds, candicidin and antimycin, that are
active against Escovopsis. It was recently shown that a mutant strain deficient in both of
these antifungal compounds was still able to inhibit growth of Escovopsis suggesting that
the ant-associated Streptomyces is able to produce other antifungal compounds. The
genome of the Streptomyces species was shown to contain several unassigned NRPS and
PKS biosynthetic clusters that may produce antimicrobials. Whether antifungal
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compounds are produced at high enough levels in nature to protect the fungal gardens
remains to be determined.
Cumulative data supports the idea that in nature most antimicrobial compounds
are produced at sub-inhibitory concentrations (SIC). The concentrations of antimicrobials
produced in soil environments are unlikely to reach levels seen under broth culture
conditions (54). Numerous studies have shown that antimicrobials can cause a differential
response depending on concentration. This phenomenon is referred to as hormesis. For
example, using promoter-lux reporter libraries of Salmonella typhimurium as many as 5%
of the promoters were modulated by exposure to SIC of either erythromycin or rifampicin
(49). The genes affected encoded diverse functions such as transport, virulence and DNA
repair. Furthermore, the so-called antibiotics may have different physiological and
ecological effects. Phenazines produced by Pseudomonas aeruginosa not only have
antibiotic activity but also are involved in the transfer of electrons when oxygen is
unavailable (55). Likewise, isopropylstilbene, a major antibiotic compound produced by
Photorhabdus luminescens, also inhibits insect immune responses and serves as a
developmental signal for the nematode partner, Heterorhabditis bacteriophora (56, 57).
Finally, a large number of clinically relevant antibiotics induce biofilm formation in a
variety of bacteria exposed to SIC of the antibiotic (48).
The antimicrobial activity of X. nematophila was discovered over 30 years ago (1,
36). Since then numerous antimicrobial compounds and biosynthetic gene clusters have
been characterized. While it has been assumed that these compounds play a role in
interspecies competition very little is known about the production of antimicrobials in the
host and whether they function in other aspects of the life cycle of X. nematophila.
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1.4. Dissertation objectives
X. nematophila engages in a defensive mutualistic relationship with a nematode
partner and functions as a pathogen in the insect host. During the infectious phase of its
life cycle X. nematophila faces competition with microbes growing in the hemolymph
and an activated insect immune response. It has never been conclusively established that
the actual biological competitors for X. nematophila are the insect gut microflora. In this
study we explore the microbial population dynamics that occur in the infected host
hemolymph, which will help shed light on the interactions of X. nematophila with its
competitors, and whether these interactions involve secondary metabolite antimicrobials.
Numerous antimicrobial compounds have been isolated from broth cultures of X.
nematophila but their production and role in competition has never been studied in more
biologically relevant media or host systems. Also, despite the large field of study of small
molecule antibiotics by bacteria, our knowledge of whether they are produced in natural
environments is limited. Their role as antimicrobial agents has also been tested only
against lab strains and never biologically relevant competitors. Finally, secondary
metabolites may serve as developmental signals for the nematode and function in as yet
unidentified processes in the life cycle of X. nematophila. The goal of this study is to
determine the microbial competitors to X. nematophila and the relative contributions of
X. nematophila antimicrobials and insect immune response to the microbial population
dynamics in the insect hemolymph. Using biologically relevant competitors, we
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determine the effect of growth and assay conditions on antimicrobial determination, the
differential competition tactics of X. nematophila against different competitors, and the
role of an unidentified NRPS gene cluster.

By creating mutant strains deficient in

antimicrobial production we suggest other possible functions of antimicrobial compounds
in the life cycle of X. nematophila.
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Chapter Two
Microbial Population Dynamics in the Hemolymph of Manduca sexta
Infected with Xenorhabdus nematophila and the Entomopathogenic
Nematode, Steinernema carpocapsae

The text of this chapter is a slightly modified version of the accepted paper:
Singh S, Reese JM, Casanova-Torres ÁM, Goodrich-Blair H, Forst S. 2014.
Microbial population dynamics in the hemolymph of Manduca sexta infected with
Xenorhabdus nematophila and the entomopathogenic nematode, Steinernema
carpocapsae. Appl. Environ. Microbiol. 80: In press.
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2.0. Introduction
Bacteria rarely exist in isolation and are usually found in multispecies populations
in which competition for resources and space becomes a prime factor in driving
community dynamics and evolutionary processes. For pathogens there exists a dual
challenge of competing with other microbes in the environment and evading or
suppressing activated immune responses. Competition under laboratory conditions has
been extensively studied but much less is known about the competitive interactions in a
host organism. The tripartite system involving the symbiotic-pathogenic bacterium
Xenorhabdus nematophila, an entomopathogenic nematode and an insect host provides a
tractable model to study microbial competition and immune suppression in a natural
biological environment.
Xenorhabdus nematophila exhibits a bimodal life cycle: it establishes a speciesspecific mutualistic relationship with the entomopathogenic nematode Steinernema
carpocapsae and launches a pathogenic attack on susceptible insect larvae (1-5). The
infective juvenile (IJ) stage of the nematode invades insect larvae through natural
openings such as the mouth or anus, punctures the midgut to enter the hemocoel (body
cavity) and releases X. nematophila into the hemolymph (2). X. nematophila is not
detected in the hemolymph 5 h post-invasion while by 12 h it colonizes the connective
tissue surrounding the anterior midgut (6). In the hemocoel X. nematophila functions as a
pathogen by suppressing the host immune system and secreting insect toxins, cytotoxins,
and hemolysins that participate in killing the host (4).
An initial step towards mounting an insect immune response is recognition of
foreign microbes by pattern recognition proteins (PRP) such as hemolin, peptidoglycan
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recognition protein (PGRP), and immulectins (7, 8) . PRPs bind conserved microbialassociated molecular pattern (MAMP) motifs and initiate the immune response. The
immune response comprises humoral and cellular pathways. Humoral immune responses
include stimulation of phospholipase A2 (PLA2) activity that releases arachidonic acid
from membrane phospholipids resulting in the production of eicosanoids that activate
hemocytes and induce expression of antimicrobial peptide (AMP) genes (9). Cecropin is
a bacteria-inducible AMP that disrupts bacterial cell membranes leading to cell lysis (10).
Cellular immune responses use circulating hemocytes to bring about phagocytosis,
aggregation, and encapsulation or nodulation (11). A central response of the innate
immune system is the conversion of prophenoloxidase (ProPO) to the active
phenoloxidase (PO) involved in quinone synthesis and formation of melanin that binds to
the microbial cell surface functioning as an opsonin. X. nematophila produces several
compounds that suppress aspects of the insect innate immune response. These include
tyrosine-derived cell surface molecules (rhabduscin) that directly inhibit PO activity (12)
and the monoterpenoid compound benzylideneacetone (13) that inhibits PLA2 activity,
reduces AMP synthesis and blocks PO activity (9, 14). Interestingly, benzylideneacetone
itself has antimicrobial activity (13).
Suppression of insect host immunity may benefit X. nematophila but can also
facilitate the growth of competitors in the insect hemocoel and it is therefore important to
understand the broader microbial ecology of a X. nematophila-infected host. The tobacco
hornworm, Manduca sexta, is a model insect commonly used to study X. nematophila
pathogenicity and suppression of host immune responses (11). The intestinal microbiota
of M. sexta has been characterized in insects grown on different diets. In insects raised on
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the natural diet of tobacco leaves Enterococcus spp. were the predominant species
isolated from the gut(15). Enterococcus faecalis is a common gut microbe isolated from
Lepidoptera (16) and several other orders of insects (17). Recently, it was shown that
injection of a clinical strain of E. faecalis into the hemocoel of M. sexta caused insect
death whereas when this strain was introduced into the gut it persisted without overt
damage to the host. However, when E. faecalis-colonized insects were also fed the poreforming insecticidal Bt toxin, E. faecalis translocated into the hemocoel, causing insect
immune response induction and death (18).
Whereas X. nematophila produces diverse antimicrobial products in culture, the
role they play in suppressing microbial competitors during infection remains poorly
understood. Xenocoumacin (Xcn) is the major soluble antibiotic produced by X.
nematophila in broth culture (19) and has been detected in the infected wax worm,
Galleria mellonella (20). Xcn1, the most active form of xenocoumacin, is produced at
high levels and subsequently converted to the less active compound, Xcn2, to avoid selftoxicity (21).
Very little is known about microbial competition during the early stages of
invasion of the insect hemocoel by S. carpocapsae. In the present study we address
several unanswered questions. Do microbes translocate from the insect gut into the
hemolymph when the nematode invades the hemocoel? Do gut microbes proliferate in
the hemocoel? What are the population dynamics of competitors and X. nematophila
during the early stage of infection? Do the competitors exhibit different sensitivities to
the antimicrobial products of X. nematophila?
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2.1. Materials and Methods
2.1.1. Bacterial strains and growth conditions
Xenorhabdus nematophila AN6/1 (phase 1, opaque colonies) was used as the
wild-type strain. The E. faecalis human clinical strain OG1RF (22) was kindly provided
by R. van der Hoeven. All bacteria used in this study were grown at 30°C in either LuriaBertani broth (LB) (23) or on LB agar plates (15 g/l agar). After preparation, media were
maintained in the dark. Strains grown overnight in LB broth (supplemented with 50
µg/ml ampicillin for X. nematophila) were subcultured (1:20) in 5 ml of fresh LB broth
and growth was monitored by turbidity using a Klett-Summerson colorimeter or via
optical density measurement at 600 nm (OD600). Final bacterial cultures were normalized
using OD600 values. Grace’s insect culture medium (Gibco) was used to dilute cultures
for insect injections and dilutional plating.

2.1.2. Sources, treatments and rearing of Manduca sexta larvae
Unless otherwise mentioned, M. sexta eggs were obtained from the insect colony
at the University of Wisconsin – Milwaukee. Eggs were placed in clean plastic cups
along with diet and incubated in an insect incubator with at 16:8 h light:dark photoperiod
at room temperature. After hatching, larvae were moved to clean boxes and provided
fresh diet. Boxes were cleaned daily and larvae were fed regularly. The fourth instar stage
was used for all experiments. Commercial premixed diet (North Carolina State University
Insectary, hence referred to as NCSU) without added antibiotics was the primary initial
diet used, later prepared from individual ingredients. The diet was prepared according to
supplier instructions (24). For some experiments, the commercially available Gypsy moth
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diet (High Wheat Germ Diet, MP Biomedicals) prepared according to manufacturer’s
instructions without added antibiotics was used. The diets were swabbed as well as
homogenized then plated on LB agar plates and were shown to be devoid of microbial
contamination.

2.1.3. Gut dissections and isolation of gut microbes
Fourth instar larvae anaesthetized on crushed ice for 15-20 min were surface
sterilized by submerging in 70% cold ethanol. Dissecting implements were sterilized with
ethanol and rubber gloves were worn during the procedure. The insect gut was exposed
by dorsal incision and the dissected gut was placed in a sterile 1.5 ml tube containing
between 200-500 µl of LB broth. The tissue was homogenized by grinding for 2 min
using a Kontes pellet pestle micro grinder (Kimble Chase). Serial dilutions of the
suspension were made in LB broth and plated on LB agar followed by incubation at 30°C
for 48 h. The resulting colonies were categorized based on colony morphology,
pigmentation and surface properties. Representative colonies of each type were patched
to fresh plates and used for colony PCR to amplify 16S rRNA genes. Briefly, a small
portion of the colony was resuspended in 3µl of nuclease-free water and boiled for 4 min.
PCR amplification (25 µl final volume) was performed using the GoTaq® Green Master
Mix kit (Promega) with 1 µl each of the 10µM universal 16S rRNA (bacterial) gene
primers,

11F

(5’-GTTTGATCCTGGCTCAG-3’)

and

1512R

(5’-

ACGGYTACCTTGTTACGACTT-), obtained from Integrated DNA Technologies, Inc.
The PCR reaction was carried out for 30 s at 94 oC, 30 s at 50oC and 2 min at 72oC for 30
cycles. If direct colony PCR did not yield products, DNA extracted from overnight
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cultures using the PurElute™ Bacterial Genomic Kit (Edge BioSystems) was used in the
PCR reaction. The PCR product was checked on an agarose gel and purified using the
GENECLEAN® Turbo kit (MP Biomedicals). Nucleotide sequence analysis was
performed at the University of Chicago Cancer Research DNA Sequencing and
Genotyping Facility. Trimmed sequences were used for BLASTN analysis for genus and
species identification. For E. faecalis, S. saprophyticus, A. viridans, the sequences were
at least 1000 nucleotides long and showed 99% identity along the entire length. In cases
in which PCR amplification was unsuccessful, microscopic analysis was performed using
a wet mount to identify large oval, nucleated and budding cells, characteristic of yeast.

2.1.4. Natural infections, isolation of insect hemolymph and determination of
microbial composition
For natural infections, Steinernema carpocapsae infective juveniles (IJs) carrying
wild-type X. nematophila were used. IJs washed and resuspended in sterile water were
pipetted on wet filter paper lining the bottom of a plastic cup, at 200 IJs/insect. Several
fourth instar larvae were added to each cup. To extract hemolymph at various times,
larvae were anaesthetized on ice, placed in a bath of 70% ethanol for 30 s and air dried. A
cut was made just below the last proleg and hemolymph was drained into sterile 1.5 ml
tubes. Hemolymph was isolated from individual larvae and subsequently pooled for each
time point. For culture-dependent determination of microbial composition of hemolymph,
serial dilutions of the extracted hemolymph were plated in triplicate on LB agar plates
that were incubated at 30°C for 48 h. Colonies were grouped according to colony
morphology, color, shape and surface properties. At least three colonies of each type
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were patched on LB agar and stored as glycerol stocks at -80°C. From the patch plates,
colony PCR and BLASTN analysis was performed and used for species identification.
Colonies in which 16S rRNA gene amplification was not successful were analyzed
microscopically. Microscopic analysis using wet mounts revealed yeast cells. From the
same hemolymph samples culture-independent analysis was carried out using 1 ml of
pooled hemolymph that was centrifuged at 8000 r.p.m. at 4°C for 10 min. DNA was
extracted from the bacterial pellet using the PurElute™ Bacterial Genomic Kit (Edge
BioSystems). Amplified 16S rRNA gene sequence was cloned into Escherichia coli using
the pGEM® - T Easy Vector kit (Promega). At least 20 positive clones were picked for
each time point and colony PCR using SP6 and T7 primers was performed to amplify the
cloned 16S rRNA genes. The PCR products were sequenced and characterized using
BLASTN analysis as described above. The experiments were performed at least twice,
with reproducible results. The experiments were performed at similar times of the day,
with similar feeding cycles for the insects.

2.1.5. Antibiotic overlay assay
Subcultures of X. nematophila were grown to exponential phase and 6 µl samples
of the culture were spotted on LB agar plates and incubated for 24 h. The bacteria were
exposed to chloroform fumes for 30 min followed by air drying for 30 min. One milliliter
of overnight culture of the indicator bacterial strain was added to 12 ml top agar (LB with
0.7% agar) which was then poured to form a thin layer over the X. nematophila colonies
(1, 25). The plates were incubated at 30°C for 48 h. Zones of inhibition were measured in
millimeters. The overlay assays were performed four times, with nearly identical results.
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2.1.6. In vivo competitions
X. nematophila, E. faecalis and S. saprophyticus were subcultured in LB broth,
grown to exponential phase, normalized and diluted in Grace’s medium. For the
competition experiments three different ratios were used: a) 1:1 mixture of 104
CFU/insect of the appropriate bacterial cultures, b) mixture consisting of 104 CFU/insect
X. nematophila and 105 CFU/insect E. faecalis (1:10 ratio), and c) mixture consisting of
105 CFU/insect X. nematophila and 104 CFU/insect E. faecalis (10:1 ratio). Fifty
microliters of the mixtures were injected per insect using BD 1ml Sub-Q, 0.45 mm x 16
mm syringes (Becton Dickinson Co.) mounted on a Stepper™ Repetitive Dispensing
Pipette (Dymax Corp.). Fourth instar M. sexta larvae were anaesthetized by placing on
crushed ice for 15-20 min and the area around the horn was cleaned using 70% ethanol
before each injection. Grace’s medium was injected as a negative control. The insects
were placed in plastic cups and hemolymph was collected at designated time points,
serially diluted and plated on LB agar as described above. Three to four larvae were used
per time point and the experiment was performed at least twice, with reproducible results.
Again, the experiments were performed at similar times of the day, with similar feeding
cycles for the insects.

2.1.7. Immunosuppression by X. nematophila in the presence of natural competitors
derived from M. sexta gut microbiota
Two fifth instar larvae of M. sexta were injected with ~104 CFU/insect of the
following: X. nematophila, E. faecalis, S. saprophyticus, X. nematophila+E. faecalis, or
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phosphate-buffered saline (PBS, as negative control). Insect fat body tissue (a major site
for immune protein expression) was dissected 16 h post-injection, followed by total RNA
extraction using TriZol reagent (Invitrogen). For reverse transcription, 5 µg of total RNA
were treated with RQ1 RNase-free DNase I (Promega). Reverse transcription was
performed using the Mg primer: 5’-CGGGCAGTGAGCGCAACGTTTTTTTTTTTT-3
′ (Integrated DNA Technologies) and AMV Reverse Transcriptase (Promega). cDNA
was used as template for quantitative real time PCR (qRT-PCR). qRT-PCR was
performed with Bullseye EvaGreen (MidSci) on a Bio-Rad iCycler. Transcript levels of
cecropin were measured and normalized against rpS3 using the following primers:
cecropin-forward (5’- GGTCAAAGGATTCGTGACGC-3’) and cecropin-reverse
(5’-TTTGATTGTCCTTTGAAAATGGCG-3’), rpS3-forward
(5’-ACTTCTCAGGCAAGGAGTGC-3’)

and

rpS3-reverse

(5’

GTCACCAGGATGTGGTCTGG-3’). Data were analyzed as previously described (26).
Briefly, Ct values were normalized by calculating the ratio between the reference gene
and the gene of interest and presented as a ratio between infected versus PBS injected
larvae. Data were statistically analyzed using Mixed Effect ANOVA with a Tukey’s posthoc test for multiple comparisons on normalized Ct values (SAS Software). The
experiment was performed four times.

2.1.8. Virulence comparison of gut and human OG1RF clinical strains of E. faecalis
Eggs obtained from Carolina Biological Supply Company raised on NCSU diet
were used. Both strains of E. faecalis along with X. nematophila were grown overnight
then subcultured in LB. Exponential phase cultures were normalized to obtain similar
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CFUs and these cultures were diluted in Grace’s medium for injection. Fifty microliters
of diluted culture were injected per larva in varying doses: 104 CFU/insect for X.
nematophila, and 104, 105, 106 CFU/insect for both E. faecalis strains. Injections were
performed as described above, using a BD 1ml Sub-Q, 0.45 mm x 16 mm syringe
(Becton Dickinson Co.) mounted on a Stepper™ Repetitive Dispensing Pipette (Dymax
Corp.). Injected larvae were put in cups along with some food and moved to the insect
incubator where they were observed for mortality for up to 69 h. Six larvae were used per
condition and the experiment was performed twice with reproducible results.

2.1.9. GenBank accession numbers
The GenBank accession numbers for 16S rRNA sequences are as follows: E.
faecalis - KF709388, S. saprophyticus - KF709389, A. viridans - KF709390.

2.2. Results
2.2.1. Translocation of gut microbiota to the hemolymph during natural infection
To address the question of whether or not insect gut microbiota translocate into the
hemocoel during S. carpocapsae-X. nematophila infection, we first characterized the gut
microbial community of our laboratory colony of M. sexta, since the gut microbiota of M.
sexta can vary widely depending on the diet used to raise the insects (Table 3). In larvae

TABLE 2. Published diversity of gut microbiota of Manduca sexta
Insect Diet

Natural diets
Solanum dulcamara
(Nightshade)

Nicotiana tabacum
(Tobacco)
Artificial diets
NCSU Insectary

USDA, Hamden
formulaa

a

Antibiotics
Added

Egg Source

Egg
Treatment

Major genera
identified

Method of
identification

Reference

None

Lab colony

None

Bacillus,
Serratia,
Candida

Culturedependent

Toth-Prestia,
1988

None

Lab colony

None

Enterococcus

Cultureindependent

Brinkmann, 2008

None

Lab colony

Bleach

Culturedependent

van der Hoeven,
2008

Kanamycin,
Streptomycin

Lab colony

Bleach

Pediococcus
Micrococcus,
Staphylococcus
Paenibacillus,
Microbacterium,
Bacillus,
Methylobacterium

None

Carolina Biological Supply

Tween 80,
Bleach

Enterobacter,
Klebsiella

Cultureindependent

Penicillin,
Gentamicin,
Rifampicin,
Streptomycin

Carolina Biological Supply

Tween 80,
Bleach

None

Cultureindependent

Culturedependent

Broderick, 2004

Contains Chlortetracycline
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raised on nightshade, Bacillus spp., Serratia spp. and yeast (Candida) were the dominant
microbes isolated (27). In M. sexta larvae raised on the natural diet of tobacco leaves
Enterococcus spp. were the dominant species isolated from the intestine (15). In contrast,
a range of Gram-positive and Gram-negative bacteria were isolated from the intestines of
larvae derived from bleached eggs raised on different artificial diets (16, 28). Addition of
antibiotics to the diet dramatically altered or eliminated the microbial gut community.
I characterized the microbial community of M. sexta larvae grown on two
different commercially available artificial diets, North Carolina State University (NCSU)
diet and Gypsy moth diet. In each experiment a portion of the population was used to
dissect the intestine to analyze the gut microbial community and a portion was exposed to
S. carpocapsae to assess the microbial population in the hemolymph of infected larvae
during the early phase of infection (Table 3). Following dilution plating, colonies were
grouped based on morphology and pigmentation. Representative isolates were subjected
to 16S rRNA gene sequencing for species identification. All species could be
distinguished by colony morphology and pigmentation with the exception of E. faecalis
and Aerococcus viridans that were combined in a single group.
In insects raised on NCSU diet, Klebsiella oxytoca and Staphylococcus
saprophyticus were the dominant gut microbes in Exp. 1, while E. faecalis and S.
saprophyticus were dominant in Exp. 2. In insects raised on Gypsy moth diet
Enterococcus mundtii, S. saprophyticus and yeast were major gut microbes in Exp. 3
while yeast was the major gut microbe isolated in Exp. 4. Thus, Enterococcus spp. and S.
saprophyticus were dominant in insects raised on both diets while yeast was more
prevalent in insects raised on the Gypsy moth diet.

TABLE 3. Transfer of microbiota from the gut to the hemolymph during natural infection of Manduca sexta
Experiment

a

Insect diet

1

NCSU Insectary

2

NCSU Insectary

Gut
Major isolates
K. oxytoca
S. saprophyticus

Hemolymph
Major isolates
CFU/mla
K. oxytoca
3.7 × 105
S. saprophyticus
1.0 × 104

E. faecalis
S. saprophyticus

E. faecalis/A.viridans
Yeast
S. saprophyticus

4.2 × 104
2.2 × 104
5.0 × 102

3

Gypsy moth

E. mundtii
Yeast
S. saprophyticus

E. mundtii
Yeast
S. saprophyticus

2.5 × 107
4.3 × 106
1.0 × 104

4

Gypsy moth

Yeast

Yeast

1.6 × 104

All CFU/ ml values measured at 7.5 h post-infection except Experiment 3 for which it was at 18
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To determine if gut microbiota can translocate from the gut to the hemocoel during
natural infection, hemolymph was dilutionally plated and the resulting colonies were
characterized as described above. In all experiments the major isolates identified in the
gut were also microbes that were dominant in the hemolymph early in infection (Table
3). In control experiments no colonies were obtained from hemolymph collected from
uninfected insects. These findings indicate that gut microbes are translocated into the
hemocoel when the invading nematode penetrates the intestine of M. sexta.

2.2.2. Microbial population dynamics in hemolymph of M. sexta infected with S.
carpocapsae IJs
To assess temporal fluctuations in microbial populations in the hemocoel in M.
sexta naturally infected with S. carpocapsae in Exp. 2 hemolymph was obtained at
various times post-infection and microbial species were identified as described above.
The microbial population was diverse early in infection at 5 h and 7.5 h (FIG. 2.1). E.
faecalis/A. viridans were dominant while S. saprophyticus, other minor species and yeast
were present at lower levels. X. nematophila was detectable at 7.5 h. By 18 h X.
nematophila became the dominant species, E. faecalis/A. viridans persisted and the other
species disappeared. The relative levels of E. faecalis/A. viridans increased at 24 h while
X. nematophila was dominant at later times. The growth of X. nematophila and E.
faecalis/A. viridans in the hemolymph at each time point was monitored in the same
experiment (Exp. 2) by determining colony forming units per ml (CFU/ml) of
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FIG. 2.1. Microbial population dynamics in hemolymph of M. sexta naturally
infected with S. carpocapsae. M. sexta larvae were exposed to S. carpocapsae for
various times over a 48 h period. At indicated times hemolymph was extracted and
serially diluted and resulting colonies were grouped by morphology and pigmentation.
Species were identified by 16S rRNA gene sequencing. The species isolated were: X.
nematophila (black bars), E. faecalis/A. viridans (light gray striped bars), yeast (dark gray
bars), S. saprophyticus (white hatched bars), and other minor bacteria (white bars),
including small percentages of Pseudomonas spp. and Brachybacterium spp. Data are
represented as the percentage of each species relative to the total colonies counted at each
timepoint.
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FIG. 2.2. Microbial population dynamics in hemolymph of M. sexta naturally
infected with S. carpocapsae. Total colony forming units per ml of hemolymph
(CFU/ml) of X. nematophila (black bars) and E. faecalis/A. viridans (light gray striped
bars) obtained at each time point shown in FIG. 2.1.
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FIG. 2.3. Microbial population dynamics in hemolymph of M. sexta naturally
infected with S. carpocapsae. 16S rRNA gene clones obtained from total microbial
genomic DNA in infected insect hemolymph (see FIG 2.1) were sequenced and species
were identified by BLASTN analysis. Species identified were X. nematophila (black
bars), E. faecalis (light gray bars), A. viridans (white striped bars), S. saprophyticus
(white hatched bars), and other bacteria (white bars). “Others” represent minor
percentages of: Brachybacterium spp., Klebsiella spp., Paracoccus spp., and Pediococcus
spp. Data are represented as percentage of clones of each species relative to the total
clones at each time point.

42

hemolymph (FIG. 2.2). At 7.5 h the population of E. faecalis/A. viridans had reached
4x104 CFU/ml while X. nematophila was present at 103 CFU/ml. By 18 h X. nematophila
had reached 4x105 CFU/ml while the population of E. faecalis/A. viridans increased at a
slower rate during this period but began to increase more rapidly by 24 h. At later times
the population of X. nematophila increased rapidly while E. faecalis/A. viridans
continued to increase at a slower rate than X. nematophila resulting in the higher
percentage of X. nematophila seen in FIG. 2.1. In these experiments it was difficult to
reliably obtain CFU/ml data after 48 h due to degradation of insect tissues and increased
viscosity of the hemolymph.
To determine if the culture-dependent analysis of microbial population dynamics
was representative and not biased against unculturable species I carried out cultureindependent analysis of the microbial community in the hemolymph of infected insects in
the same experiment (Exp. 2, FIG. 2.3). This approach also allowed us to determine the
relative levels of E. faecalis and A. viridans in the population. The culture-independent
analysis identified the same pattern of population fluctuation as was observed with the
culture-dependent approach. The microbial population was diverse early in infection (7.5
h). At this time E. faecalis was dominant while other species were present at lower
levels. By 18 h and 24 h X. nematophila had become the dominant species, E. faecalis
persisted and the other species including A. viridans and S. saprophyticus had
disappeared. X. nematophila was the only species isolated at later times in the cultureindependent analysis most likely due to the limited number of 16S rRNA gene clones
sequenced in this experiment.
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The natural infection experiment was repeated and temporal fluctuations in
microbial populations in the hemocoel were monitored as described above. The results
were similar to Exp. 2 except that S. saprophyticus was not detected during the early
phase of infection and the level of yeast was noticeably higher. By 18 h X. nematophila
was dominant, E. faecalis/A.viridans continued to persist and yeast had disappeared.
Together, these findings establish that diverse gut microorganisms translocate into the
hemocoel during invasion, with E. faecalis/A. viridans dominating early in infection. By
18 h X. nematophila becomes the dominant species, E. faecalis/A. viridans persist (FIG.
2.2) while other species disappear.

2.2.3. Sensitivity of competitors to X. nematophila antibiotics
To assess the possibility that antibiotics produced by X. nematophila contributed
to the population fluctuations observed during infection, the sensitivities of S.
saprophyticus, E. faecalis, A. viridans and yeast were analyzed by diffusion overlay
assays (FIG. 2.4). S. saprophyticus was the most sensitive (27 mm zone of inhibition) to
antibiotics produced by X. nematophila, A. viridans was moderately sensitive (16 mm)
and yeast was somewhat less sensitive (12 mm). Interestingly, E. faecalis was the most
resistant strain (9 mm, hazy zone) suggesting that its persistence during later stages of
infection may be due, in part, to its resistance to X. nematophila antibiotics.

2.2.4. In vivo competition in M. sexta
During natural infection competitors such as S. saprophyticus, A. viridans and
yeast disappeared early in infection while E. faecalis persisted (FIG. 2.1, 2.2, 2.3). To
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FIG. 2.4. Antibiotic activity of X. nematophila against the microbes present in the
insect hemolymph. Antibiotic overlay assays were performed with X. nematophila
against the following strains obtained from infected insect hemolymph: S. saprophyticus,
A. viridans, yeast, E. faecalis. The diameter of the zone of inhibition is proportional to the
sensitivity of the competitors to X. nematophila antibiotics.
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FIG. 2.5. In vivo growth of isolates in M. sexta hemocoel after injection. Insects were
injected with 104 CFU/insect of X. nematophila (black bars), E. faecalis (light gray bars),
S. saprophyticus (white hatched bars) or A. viridans (white striped bars). Hemolymph
recovered at 8 and 24 h post-injection was dilutionally plated. Data are represented as
CFU/ml of each bacterial species at 8 and 24 h. Statistically significant differences
(P<0.05) between the two timepoints in a group are indicated by an asterisk. Statistical
analysis was performed using a two-tailed paired Student’s t-test.
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further dissect the competitive events that occur early in infection we assessed the ability
of individual species to compete with X. nematophila. To first determine if the individual
species were able to persist and proliferate alone in the hemocoel, S. saprophyticus,
E.faecalis and A.viridans were injected individually into M. sexta and growth was
monitored for 24 h. S.saprophyticus persisted at 8 h and the cell density increased at 24 h
(FIG. 2.5). E. faecalis persisted at 8 h while cell density decreased at 24 h. A. viridans
was present at low levels at 8 h and was detectable at lower levels at 24 h. Thus, all
strains persisted at 24 h, with S. saprophyticus able to survive better than either E.
faecalis or A. viridans.
To evaluate the competitive interactions between S. saprophyticus and X.
nematophila, both bacteria were co-injected into M. sexta (FIG. 2.6. A). S. saprophyticus
was eliminated by 24 h when co-injected with X. nematophila. In contrast, S.
saprophyticus was not eliminated by 24 h when co-injected with E. faecalis (FIG. 2.7). S.
saprophyticus and E. faecalis also did not display any antibiotic activity against each
other in overlay assays (FIG. 2.8). When E. faecalis was co-injected into M. sexta (FIG.
2.6. B) it proliferated to high levels in the presence of X. nematophila while it did not
grow significantly better when co-injected with S. saprophyticus (FIG. 2.7). These
findings are consistent with the population dynamics we observed during natural
infection and suggest that relative antibiotic resistance and possible syntrophic effects
when present along with X. nematophila allowed E. faecalis to grow in the insect
hemocoel. Another possibility could be the suppression of the host immune system by X.
nematophila which might aid E. faecalis growth (see below).
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FIG. 2.6. In vivo growth after 1:1 co-injections of X. nematophila with S.
saprophyticus or E. faecalis into M. sexta. A. Insects were co-injected with a 1:1
mixture of X. nematophila (black bars) and S. saprophyticus (white hatched bars). 104
CFU/insect of each species were injected. B. Insects were co-injected with a 1:1 mixture
of X. nematophila (black bars) and E. faecalis (light gray bars). 104 CFU/insect of each
species were injected. Hemolymph recovered at 8 and 24 h post-injection was
dilutionally plated. Data are represented as CFU/ml of each bacterial species at 8 and 24
h.
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FIG. 2.7. In vivo growth after 1:1 co-injection of E. faecalis and S. saprophyticus into
M. sexta. Insects were co-injected with a 1:1 mixture of E. faecalis (light gray bars) and
S. saprophyticus (white hatched bars). 104 CFU/insect of each species were injected.
Hemolymph recovered at 8 and 24 h post-injection was dilutionally plated. Data are
represented as CFU/ml of each bacterial species at 8 and 24 h.
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FIG. 2.8. Antibiotic overlay assay testing mutual activity of E. faecalis and S.
saprophyticus. The lack of a zone of inhibition indicates that E. faecalis and S.
saprophyticus do not possess antibiotic activity against each other.

FIG. 2.9. In vivo competition between X. nematophila and E. faecalis in M. sexta co-injected at varying ratios. A. Insects were
injected individually with 105 CFU/insect of either X. nematophila (black bars) or E. faecalis (light gray bars). B. Insects were coinjected with a 1:10 mixture of X. nematophila (104 CFU/insect) and E. faecalis, (105 CFU/insect). C. Insects were co-injected with a
10:1 mixture of X. nematophila (105 CFU/insect) and E. faecalis (104 CFU/insect). Hemolymph recovered at 8 and 24 h postinjection was dilutionally plated. Data are represented as CFU/ml of each bacterial species at 8 and 24 h.
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During the early phase of natural infection the levels of E. faecalis were significantly
higher than those of X. nematophila (FIG. 2.1, 2.2, 2.3). To more closely mimic the
relative cell density that occurs during natural infection, M. sexta was co-injected with a
10:1 ratio of E. faecalis/X. nematophila (FIG. 2.9. B). As expected, E.faecalis
proliferated in the presence of X. nematophila. Since the cell density of X. nematophila
was significantly higher than E. faecalis at later times in infection, I also co-injected M.
sexta with 10-fold more X. nematophila than E. faecalis (FIG. 2.9. C). Again, E. faecalis
was able to proliferate in the presence of X. nematophila. These findings show that the
growth of E. faecalis in the hemolymph was enhanced by the presence of X. nematophila
(compare FIG. 2.5 with FIG. 2.6 and 2.9) even when the latter was present at 10-fold
higher levels.

2.2.5. Induction of antimicrobial peptide transcripts by E. faecalis is suppressed by
X. nematophila
Proliferation of E. faecalis in the presence of X. nematophila suggested that this
strain might benefit from suppression of the host immune response by X. nematophila. To
explore this possibility, qRT-PCR analysis was performed to determine relative transcript
levels of cecropin in insects injected with either X. nematophila or E. faecalis, or coinjected with both bacteria. Cecropin transcript was detectable in insects injected with X.
nematophila and was induced to high levels in insects injected with E. faecalis relative to
PBS-injected controls (FIG. 2.10). In insects co-injected with both bacteria the transcript
level of cecropin was similar to or less than those injected with X. nematophila alone.
These results support the idea that X. nematophila suppresses AMP gene expression
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FIG. 2.10. Relative cecropin transcript levels in insects injected with E. faecalis and
S. saprophyticus alone, and co-injected with E. faecalis and X. nematophila. Fifth
instar M. sexta larvae were injected with X. nematophila (black bars), E. faecalis (gray
bars), S. saprophyticus (white hatched), or co-injected with both X. nematophila and E.
faecalis (white horizontal striped bars). Insects injected with PBS (white bars) served as a
negative control for immune activation. RNA extracted at 16 h post-injection from fat
body tissue was converted to cDNA and the cDNA was used to assess the relative
transcript levels of the antimicrobial peptide cecropin (highly induced upon bacterial
challenge). Statistically significant differences between two groups are indicated by
different letters between the groups.
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induced by the presence of E. faecalis. I also found that the ability of S. saprophyticus to
survive in the hemolymph when injected alone (FIG. 2.5) could be attributed, in part, to
the lack of induction of cecropin transcripts relative to the control (FIG. 2.10).

2.2.6. E. faecalis isolated from the gut is pathogenic towards M. sexta
The persistence of E. faecalis during the early phase of infection and virulence of
a clinical strain of E. faecalis towards M. sexta (18) raised the possibility that E. faecalis
isolated from the insect gut would be pathogenic towards M. sexta. To explore this
possibility, virulence of the gut strain was compared to the clinical strain of E. faecalis
and X. nematophila (FIG. 2.11). At 22 h, 50% of the insects had died (LT50, 22 h) when
injected with X. nematophila at a dose of 104 CFU/insect while all of the insects were
dead by 25 h (LT100, 25 h). The gut strain of E. faecalis was also virulent at a higher dose
of 106 CFU/insect (LT50, 27 h; LT100, 43 h) while the clinical strain was less virulent
(LT50, 43 h) and was not able to kill 100% of the injected insects. In contrast, S.
saprophyticus injected at a dose of 106 CFU/insect did not result in mortality of M. sexta
larvae (data not shown). These results, combined with the evidence of persistence of E.
faecalis during infection, suggest the possibility that E. faecalis may contribute to
pathogenicity during natural infection of M. sexta.
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FIG. 2.11. Comparison of the virulence of E. faecalis (gut isolate), E. faecalis
(OG1RF), and X. nematophila towards M. sexta. Insects were injected with E. faecalis
at a dose of either 106 CFU/insect (squares), 105 CFU/insect (upright triangles) or 104
CFU/insect (inverted triangle). The E. faecalis (gut isolate) is represented with open
symbols and E. faecalis OG1RF is represented by closed symbols. Insects injected with
X. nematophila (104 CFU/insect) are represented by closed circles. Survival was
monitored over a period of time and virulence is depicted as percent survival.
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2.3. Discussion
The role of gut microbiota in normal health, development and disease
susceptibility has been extensively examined in several animals (28-30). The movement
of bacteria into and across intestinal epithelial cells is a major source of diseases
originating from the gastrointestinal tract. Whether native gut microbiota are translocated
into the hemocoel during natural infections of M. sexta with entomopathogenic
nematodes had not been previously studied. Here I characterize the gut microbiota of M.
sexta and the translocation of microbes into the hemocoel during the early phase of
infection by S. carpocapsae.
I show that gut microbes were translocated into the hemocoel of M. sexta
naturally infected with S. carpocapsae. During the early phase of infection the initial
population was diverse and reached cell densities of ~105 CFU/ml while X. nematophila
was barely detectable at this time. The relatively high microbial load was unexpected
since the innate immune response is rapidly induced in the presence of bacteria and yeast
(11, 31). Within hours after injection of bacteria, activated hemocytes engulf bacterial
invaders and pattern recognition proteins are induced. Microaggregation of hemocytes
has been observed 4 h after injection of M. sexta with E. faecalis (18) and Salmonella
enterica (32), and AMP genes were induced 9 h after injection of Salmonella enterica
(32). In Spodoptera exigua numerous immune response genes were induced 8 h after
injection of either E. coli or Flavobacterium (14). Several factors could account for the
microbial load observed during the early phase of infection. Since AMPs are secreted into
the insect intestine (11) it is a possibility that native microbiota may develop tolerance to
the host immune response. They might also be able to avoid host immune mediators.
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Whatever the mechanism, the induction of the immune response is apparently not
sufficient to prevent gut microbes from proliferating in the hemolymph. In addition, X.
nematophila derived antimicrobial compounds would not be present at appreciable levels
during early infection since this bacterium is present at low cell density at that time.
Antibiotic activity was not detected until 36 h after G. mellonella was injected with S.
carpocapsae (20). Thus, during the early phase of infection competitors benefit from an
apparently insufficient immune response and minimal antimicrobial deterrence.
As shown previously, gut microbiota of M. sexta can vary and may be influenced
by diet (TABLES 2 and 3). Enterococcus species were major isolates identified in Exp. 2
and Exp. 3, consistent with previous observations in M. sexta raised on the natural diet of
tobacco leaves (15). E. faecalis has been identified in the gut of Gypsy moth larvae raised
on 5 different diets (16). It was proposed that E. faecalis could modify the high alkalinity
of the larval gut and influence the microbial gut community. E. faecalis was also the
dominant microbial species isolated from the gut of G. mellonella (33) and was the only
bacterial species isolated from macerated G. mellonella (34). I show that during natural
infection E. faecalis was present in the hemolymph by 5 h, persisted at 10 h and
subsequently increased as the cell density of X. nematophila increased. A similar pattern
was observed in M. sexta co-injected with E. faecalis and X. nematophila. I also found
that E. faecalis was relatively resistant to antibiotics produced by X. nematophila.
Additionally, the transcript level of the AMP cecropin was suppressed by X. nematophila
when it was co-injected with E. faecalis, which by itself induced the up-regulation of this
gene (FIG. 2.10). These findings suggest that the combined effect of immune suppression
by X. nematophila, the relative antibiotic resistance of E. faecalis and possible syntrophic
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interactions may create conditions for E. faecalis to proliferate. Furthermore, the native
E. faecalis had, by 18 h, reached a cell density that was shown to be lethal to M. sexta
(FIG. 2.11). Thus, in insects in which E. faecalis is present in the gut, invasion by
entomopathogenic nematodes could result in its translocation to the hemocoel where it
may contribute to virulence. However, E. faecalis was not essential for virulence since
mortality of M. sexta lacking E. faecalis was similar to when it was present (data not
shown).
During later phases of infection (e.g. 18 h) X. nematophila was dominant and E.
faecalis cell density had increased while strains such as S. saprophyticus, A. viridans and
yeast had disappeared. These findings correlated with sensitivity to the antibiotics of X.
nematophila. In a previous study in which Gram-negative bacteria were sampled in the
hemolymph of G. mellonella naturally infected with S. carpocapsae, Pasteurella sp. was
the predominant species isolated at 6 h and 12 h while it had disappeared by 18 h when X.
nematophila was the only species isolated (35). The reciprocal relationship between
increasing cell density of X. nematophila and reduction of competitors suggest that
production of antimicrobial compounds may play a role in the population fluctuations in
the infected host. X. nematophila produces more than 20 antimicrobial compounds when
grown in pure culture in complex media. However, little is known about antibiotic
production in natural host environments. Proline, which is present at high levels in the
hemolymph of G. mellonella, was shown to stimulate production of some secondary
metabolites by X. nematophila grown in tryptone-yeast extract broth (36). The growth of
X. nematophila in mixed cultures in the hemolymph also creates the potential of crossspecies signaling that may induce production of antibiotics not detected in pure cultures
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(37). Further studies in M. sexta naturally infected with S. carpocapsae and antibioticdeficient strains of X. nematophila will provide greater insight into the role of
antimicrobial compounds in natural host environments.
The present findings suggest that S. carpocapsae development and colonization is
unlikely to occur in a monoculture of X. nematophila. The proliferation of competitors
could play a role in both determining the host range of S. carpocapsae and susceptibility
of the host to infection. Also, since the gut microbiota can vary considerably, the types of
competitors that are encountered in the hemolymph of different hosts may differentially
affect the ability of S. carpocapsae to reproduce. For example, co-inoculation of some
species of Xenorhabdus with axenic S. carpocapsae did not alter nematode reproduction
while other species prevented reproduction (38). Similarly, different gut microbiota may
have either neutral or antagonistic effects on nematode reproduction. How variability of
the insect gut microbiota influences S. carpocapsae development and colonization, and
insect mortality remains to be determined. It is becoming increasingly apparent that
interspecies competition that occurs during natural infection by entomopathogenic
nematodes is complex, influenced by the microbial community of the insect gut, insect
immune response, temporal and environmental control of antimicrobial products and
other microbe-nematode interactions yet to be identified.

59

2.4. References
1.

Akhurst RJ. 1982. Antibiotic activity of Xenorhabdus spp., bacteria
symbiotically associated with insect pathogenic nematodes of the families
Heterorhabditidae and Steinernematidae. J. Gen. Microbiol. 128:3061-3065.

2.

Snyder H, Stock SP, Kim SK, Flores-Lara Y, Forst S. 2007. New insights into
the colonization and release processes of Xenorhabdus nematophila and the
morphology and ultrastructure of the bacterial receptacle of its nematode host,
Steinernema carpocapsae. Appl. Environ. Microbiol. 73:5338-5346.

3.

Forst S, Clarke D. 2002. Bacteria-nematode symbiosis, p. 57-77. In Gauler R
(ed.), Entomopathogenic Nematology. CABI Publishing, Wallingford, UK.

4.

Goodrich-Blair H, Clarke DJ. 2007. Mutualism and pathogenesis in
Xenorhabdus and Photorhabdus: two roads to the same destination. Mol.
Microbiol. 64:260-268.

5.

Herbert EE, Goodrich-Blair H. 2007. Friend and foe: the two faces of
Xenorhabdus nematophila. Nat. Rev. Microbiol. 5:634-646.

6.

Sicard M, Brugirard-Ricaud K, Pages S, Lanois A, Boemare NE, Brehelin M,
Givaudan A. 2004. Stages of infection during the tripartite interaction between
Xenorhabdus nematophila, its nematode vector, and insect hosts. Appl. Environ.
Microbiol. 70:6473-6480.

7.

Casanova-Torres ÁM, Goodrich-Blair H. 2013. Immune Signaling and
Antimicrobial Peptide Expression in Lepidoptera. Insects 4:320-338.

8.

Eleftherianos I, Gokcen F, Felfoldi G, Millichap PJ, Trenczek TE, ffrenchConstant RH, Reynolds SE. 2007. The immunoglobulin family protein Hemolin
mediates cellular immune responses to bacteria in the insect Manduca sexta. Cell.
Microbiol. 9:1137-1147.

9.

Song CJ, Seo S, Shrestha S, Kim Y. 2011. Bacterial metabolites of an
entomopathogenic bacterium, Xenorhabdus nematophila, inhibit a catalytic
activity of phenoloxidase of the diamondback moth, Plutella xylostella. J.
Microbiol. Biotechnol. 21:317-322.

10.

Moore AJ, Beazley WD, Bibby MC, Devine DA. 1996. Antimicrobial activity
of cecropins. J. Antimicrob. Chemother. 37:1077-1089.

11.

Eleftherianos I, ffrench-Constant RH, Clarke DJ, Dowling AJ, Reynolds SE.
2010. Dissecting the immune response to the entomopathogen Photorhabdus.
Trends Microbiol. 18:552-560.

60

12.

Crawford JM, Portmann C, Zhang X, Roeffaers MB, Clardy J. 2012. Small
molecule perimeter defense in entomopathogenic bacteria. Proc. Natl. Acad. Sci.
U.S.A. 109:10821-10826.

13.

Ji D, Yi Y, Kang GH, Choi YH, Kim P, Baek NI, Kim Y. 2004. Identification
of an antibacterial compound, benzylideneacetone, from Xenorhabdus
nematophila against major plant-pathogenic bacteria. FEMS Microbiol. Lett.
239:241-248.

14.

Hwang J, Park Y, Kim Y, Lee D. 2013. An entomopathhogenic bacterium,
Xenorhabdus nematophila, suppresses expression of antimicrobial peptides
controlled by Toll and Imd pathways by blocking eicosanoid biosynthesis. Arch.
Insect Biochem. Physiol.

15.

Brinkmann N, Martens R, Tebbe CC. 2008. Origin and diversity of
metabolically active gut bacteria from laboratory-bred larvae of Manduca sexta
(Sphingidae, Lepidoptera, Insecta). Appl. Environ. Microbiol. 74:7189-7196.

16.

Broderick NA, Raffa KF, Goodman RM, Handelsman J. 2004. Census of the
Bacterial Community of the Gypsy Moth Larval Midgut by Using Culturing and
Culture-Independent Methods. Appl. Environ. Microbiol. 70:293-300.

17.

Steinhaus EA. 1941. A study of the bacteria associated with thirty species of
insects. J. Bacteriol. 42:757.

18.

Mason KL, Stepien TA, Blum JE, Holt JF, Labbe NH, Rush JS, Raffa KF,
Handelsman J. 2011. From commensal to pathogen: translocation of
Enterococcus faecalis from the midgut to the hemocoel of Manduca sexta. mBio
2:e00065-00011.

19.

McInerney BV, Taylor WC, Lacey MJ, Akhurst RJ, Gregson RP. 1991.
Biologically active metabolites from Xenorhabdus spp., Part 2. Benzopyran-1-one
derivatives with gastroprotective activity. J. Nat. Prod. 54:785-795.

20.

Maxwell PW, Chen G, Webster JM, Dunphy GB. 1994. Stability and activities
of antibiotics produced during infection of the insect Galleria mellonella by wo
isolates of Xenorhabdus nematophilus. Appl. Environ. Microbiol. 60:715-721.

21.

Park D, Ciezki K, van der Hoeven R, Singh S, Reimer D, Bode HB, Forst S.
2009. Genetic analysis of xenocoumacin antibiotic production in the mutualistic
bacterium Xenorhabdus nematophila. Mol. Microbiol. 73:938-949.

22.

Bourgogne A, Garsin DA, Qin X, Singh KV, Sillanpaa J, Yerrapragada S,
Ding Y, Dugan-Rocha S, Buhay C, Shen H. 2008. Large scale variation in
Enterococcus faecalis illustrated by the genome analysis of strain OG1RF.
Genome Biol. 9:R110.

61

23.
Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by
lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
24.

Yamamoto R. 1969. Mass rearing of the tobacco hornworm. 1, 2 II. larval rearing
and pupation. J. Econ. Entomol. 62:1427-1431.

25.

Volgyi A, Fodor A, Szentirmai A, Forst S. 1998. Phase Variation in
Xenorhabdus nematophilus. Appl. Environ. Microbiol. 64:1188-1193.

26.

Castillo J, Shokal U, Eleftherianos I. 2013. Immune gene transcription in
Drosophila adult flies infected by entomopathogenic nematodes and their
mutualistic bacteria. J. Insect Physiol. 59:179-185.

27.

Toth-Prestia C, Hirshfield IN. 1988. Isolation of plasmid-harboring Serratia
plymuthica from facultative gut microflora of the tobacco hornworm, Manduca
sexta. Appl. Environ. Microbiol. 54:1855-1857.

28.

van der Hoeven R, Betrabet G, Forst S. 2008. Characterization of the gut
bacterial community in Manduca sexta and effect of antibiotics on bacterial
diversity and nematode reproduction. FEMS Microbiol. Lett. 286:249-256.

29.

Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human
gut microbes associated with obesity. Nature 444:1022-1023.

30.

Sekirov I, Russell SL, Antunes LC, Finlay BB. 2010. Gut microbiota in health
and disease. Physiol. Rev. 90:859-904.

31.

Kanost MR, Jiang H, Yu XQ. 2004. Innate immune responses of a lepidopteran
insect, Manduca sexta. Immunol. Rev. 198:97-105.

32.

Park Y, Herbert EE, Cowles CE, Cowles KN, Menard ML, Orchard SS,
Goodrich-Blair H. 2007. Clonal variation in Xenorhabdus nematophila virulence
and suppression of Manduca sexta immunity. Cell. Microbiol. 9:645-656.

33.

Bucher G, Williams R. 1967. The microbial flora of laboratory cultures of the
greater wax moth and its effect on rearing parasites. J. Invertebr. Pathol. 9:467473.

34.

Isaacson PJ, Webster JM. 2002. Antimicrobial activity of Xenorhabdus sp. RIO
(Enterobacteriaceae), symbiont of the entomopathogenic nematode, Steinernema
riobrave (Rhabditida: Steinernematidae). J. Invertebr. Pathol. 79:146-153.

35.

Gouge DH, Snyder JL. 2006. Temporal association of entomopathogenic
nematodes (Rhabditida: Steinernematidae and Heterorhabditidae) and bacteria. J.
Invertebr. Pathol. 91:147-157.

62

36.

Crawford JM, Kontnik R, Clardy J. 2010. Regulating alternative lifestyles in
entomopathogenic bacteria. Curr. Biol. 20:69-74.

37.

Chandler JR, Heilmann S, Mittler JE, Greenberg EP. 2012. Acyl-homoserine
lactone-dependent eavesdropping promotes competition in a laboratory co-culture
model. ISME J. 6:2219-2228.

38.

Sicard M, Ferdy JB, Pages S, Le Brun N, Godelle B, Boemare N, Moulia C.
2004. When mutualists are pathogens: an experimental study of the symbioses
between Steinernema (entomopathogenic nematodes) and Xenorhabdus
(bacteria). J. Evol. Biol. 17:985-993.

63

Chapter Three

Differential Role of Antibiotics in the Life Cycle of
Xenorhabdus nematophila
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3.0. Introduction
Competition among microorganisms often occurs in multispecies populations,
commonly for space and nutrients, where bacteria employ various strategies to affect the
outcome in their favor. Normally, competition for limiting factors can be divided into two
general categories: exploitative competition, and interference competition (1). In
exploitative competition, the limiting nutrients are quickly utilized without direct
interaction between competitors. Interference competition, on the other hand, makes use
of direct, antagonistic interactions. One of the effectors of interference competition by
bacteria is antimicrobial compounds.

Xenorhabdus nematophila, a symbiotic,

entomopathogenic bacterium, is a known producer of a plethora of antimicrobial
compounds that are believed to assist in competition. Several of its secondary metabolite
antimicrobial compounds have been characterized and several have as yet unknown
activities, while there is genetic potential for the production of still more that are
undiscovered. Whether these antimicrobial compounds play a role in interspecies
competition, which could directly or indirectly affect symbiotic interactions with the
nematode partner or virulence towards an insect host, is still unknown. Our tripartite
model system involving the pathogenic bacterium Xenorhabdus nematophila, an
entomopathogenic nematode and an insect host provides a tractable model to identify
biologically relevant competitors, and study the role of X. nematophila antibiotics in
competition.
Xenorhabdus nematophila exhibits two distinct roles in its life cycle (2-5). In its
first role as a symbiotic partner it maintains a species-specific mutualistic relationship
with the entomopathogenic nematode Steinernema carpocapsae. X. nematophila resides
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in a specialized region of the anterior midgut of the infective juvenile (IJ) stage of the
nematode (6). The IJs invade soil-dwelling insect larvae through natural openings such as
the mouth or anus, and enter the body cavity (hemocoel) of the insect. Herein lies the
second role of X. nematophila, an insect pathogen. Once in the hemocoel, the bacteria
are released and Xenorhabdus brings about the death and bioconversion of the insect
larva by suppressing the insect immune response and producing toxins, cytotoxins and
hemolysins (4).
The most well studied antimicrobial compounds produced by bacteria are small
molecule antibiotics. Antibiotics are secondary metabolites and are often produced by
multi-enzyme assemblies called non-ribosomal peptide synthetases (NRPS) and/or
polyketide synthetases (PKS). Both of these enzyme assemblies are multi-modular and
function using various domains (FIG. A.3). The major antimicrobial compound produced
by X. nematophila in nutrient-rich broth cultures is the antibiotic xenocoumacin (Xcn), a
water-soluble, benzopyran-1-one compound, which is a product of a 14 gene NRPS-PKS
hybrid cluster (7, 8). Xenocoumacin exists in two forms: Xcn1, the more active form that
possesses antibacterial (against both Gram-positive and -negative bacteria) and antifungal
activities, and the less active form, Xcn2, which lacks antifungal activity (7). In the 14
gene biosynthetic cluster, there are 2 NRPS genes (xcnA, xcnK) and 3 PKS genes (xcnF,
xcnH, xcnL). The genes xcnM and xcnN are responsible for conversion of Xcn1 into Xcn2
(8-10). Xcn has been shown to be produced in the wax worm, Galleria mellonella, where
water extracts from macerated larvae infected with X. nematophila were shown to contain
both Xcn1 and Xcn2 (11). But the significance of xenocoumacin in the life cycle,
especially in the respective host organisms, has never been demonstrated.
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Several other NRPS gene clusters have been identified in the X. nematophila
genome. We had arbitrarily assigned these clusters letter designations A-F (FIG. 3.1).
The products of two of these clusters (B and D) have since been characterized. Cluster B
consists of 3 NRPS genes that produce lysine-rich cyclolipopeptides called PAX peptides
(peptide antibiotics-Xenorhabdus) that possess antifungal activity against human and
plant fungal pathogens, and low activity against Gram-positive and -negative bacteria
(12, 13). Cluster D consists of 3 NRPS genes that produce 6 linear, non-polar peptides
(rhabdopeptides) that possess antiparasitic activity against protozoan parasites and
cytotoxic activity against insect hemocytes (14). Rhabdopeptides were shown to be
produced in the infected insect G. mellonella, in later stages of infection. In addition, the
cyclic depsipeptide xenematide, which has activity against some Gram-positive and
Gram-negative bacteria, was shown to be synthesized by a large stand-alone NRPS gene.
(TABLE 1) (15, 16). Four other NRPS and NRPS-PKS gene clusters with the potential to
produce antimicrobial compounds have been identified in the genome of X. nematophila
(TABLE 4). These include cluster A (XNC1_2038, 2039, 2040), cluster E (XCN1_2299,
2300) and cluster F (XNC1_2464, 2465, 2466, 2467) and the hybrid NRPS-PKS cluster
C containing two NRPS genes (XNC1_1762, 1763) and three PKS genes (XNC1_1756,
1757, 1764). These NRPS clusters and genes have not been studied so far for their
biosynthetic capacity. In addition, the large stand-alone NRPS gene, XCN1_2022 (xtpS),
is known to encode xenotetrapeptide but its function remains unknown (17).
Other X. nematophila compounds with known antimicrobial activity but that do
not yet have a gene cluster associated with them are indole-derivatives (active against
both Gram-positive and -negative bacteria) and benzylideneacetone (antibacterial against
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FIG. 3.1. NRPS gene clusters in the genome of X. nematophila. NRPS genes are
colored red and blue and the PKS genes are colored yellow. The genes in red were
inactivated for mutant construction.

68

TABLE 4. NRPS and PKS clusters in X. nematophila with unidentified activity
Cluster
A

Type
NRPS

Number of genes
3

Genes
XNC1_2040, 2039, 2038

C

NRPS
PKS

2
3

XNC1_1763, 1762
XNC1_1764, 1757, 1756

E

NRPS

2

XNC1_2299, 2300

F

NRPS

4

XNC1_2764, 2765, 2766, 2767

-

NRPS

1

XNC1_2022
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five plant pathogenic strains tested) (18-20). Nematophin, another indole-derived
compound, has antibacterial activity against Bacillus sp., Staphylococcus spp. and some
antifungal activity,and is not known to be synthesized by NRPS or PKS genes (21). Other
small molecules include the non-polar di-peptide derivatives xenortide A and B that lack
antibacterial, antifungal, and insecticidal activity against the strains tested (15).
While the activities of some of these compounds have been elucidated, it largely
remains unclear what their role is in natural biological conditions. Antibiotic production
is mostly studied in laboratory culture conditions, often in nutrient-rich media, when
antibiotics are produced in high concentrations. Additionally, these compounds are tested
against a chosen set of indicator organisms, which may not have any biological relevance
to the producer organism. It has been proposed that antibiotics are usually produced in
sub-inhibitory concentrations in natural environments and under such conditions can
participate in signaling (22-26). Therefore, these compounds purported to have
antimicrobial activity, might not be present in high enough concentrations in the natural
environment, and might demonstrate altogether different functions. A link that connects
all the NRPS, PKS clusters together is the enzyme phosphopantetheinyl (Ppant)
transferase. This enzyme, the product of the ngrA gene, attaches the PPant moiety to the
transfer (PCP) domain of NRPS and PKS enzymes (FIG. A.4). A mutant in this gene
created in the related bacterium Photorhabdus luminescens was shown to lack antibiotic
activity and was unable to support nematode growth (27). This finding suggests that the
products of these gene clusters can have other functions, such as a developmental signal
for the nematode partner.
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We have previously demonstrated that the gut microbiota of the insect host
Manduca sexta translocates to the hemocoel during natural infection with the nematode
Steinernema carpocapsae harboring X. nematophila, and are potential competitors (28).
During early infection some competitors were eliminated such as Staphylococcus
saprophyticus that was sensitive to X. nematophila antimicrobials. Another gut microbe,
Enterococcus faecalis that was relatively resistant to antimicrobials, was dominant during
early stage infection and proliferated in the hemolymph along with X. nematophila. In
the present study we address several unanswered questions. What is the role of
xenocoumacin in competition against the biologically relevant competitors E. faecalis
and S. saprophyticus? Do any of the as yet uncharacterized NRPS, PKS clusters produce
antimicrobial compounds? Does the outcome of the competition change depending on
growth conditions? To address these questions we created NRPS mutant strains and a
ngrA mutant defective in synthesis of all NRPS, PKS-derived antimicrobials.
Additionally, we addressed the question of whether these compounds have one or more
functions in the natural host environment, which might affect the symbiotic or pathogenic
relationships of X. nematophila.

3.1. Materials and Methods
3.1.1. Bacterial strains and growth conditions
All strains and plasmids used in this study are listed in TABLE 5. Cells were
routinely grown at 30°C in either Luria-Bertani broth (LB) or on LB agar plates (15 g/l

TABLE 5. Bacterial strains and plasmids used in this study

Strain or plasmid
Strains
X. nematophila
AN6/1
ΔxcnKL
F
ngrA
ΔxcnKL:A
ΔxcnKL:B
ΔxcnKL:C
ΔxcnKL:D
ΔxcnKL:E
ΔxcnKL:F
E. coli S17-λpir
E. faecalis
S. saprophyticus
Plasmids
pSTBlue-1
pKnock-Cmr
pKnock-A
pKnock-B
pKnock-C
pKnock-D
pKnock-E
pKnock-F

Relevant genotype, phenotype or characteristic(s)

Source or
Reference

Wild-type, phase 1 variant; Ampr
AN6/1 ΔxcnKL::Kmr
AN6/1 2467::Cmr
AN6/1 1028::Cmr
AN6/1 ΔxcnKL::Kmr 2040::Cmr
AN6/1 ΔxcnKL::Kmr 2783::Cmr
AN6/1 ΔxcnKL::Kmr 1763::Cmr
AN6/1 ΔxcnKL::Kmr 2228::Cmr
AN6/1 ΔxcnKL::Kmr 2300::Cmr
AN6/1 ΔxcnKL::Kmr 2467::Cmr
recA, thi, pro, hsd(R-M+). RP4-2Tc::Mu Km::Tn7 in the
chromosome
Manduca sexta gut isolate
Manduca sexta gut isolate

Laboratory stock
D. Park
This study
This study
This study
This study
This study
This study
This study
This study

Cloning vector: Ampr Kmr
Broad-host-range suicide vector; Cmr RP4 oriT oriR6K
Internal fragment of 2040 cloned into pKnock-Cmr
Internal fragment of 2783 cloned into pKnock-Cmr
Internal fragment of 1763 cloned into pKnock-Cmr
Internal fragment of 2228 cloned into pKnock-Cmr
Internal fragment of 2300 cloned into pKnock-Cmr
Internal fragment of 2467 cloned into pKnock-Cmr

Novagen
D. Saffarini
This study
This study
This study
This study
This study
This study

Laboratory stock
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agar) (29). After preparation, media were maintained in the dark. Strains grown overnight
in LB broth (supplemented with ampicillin, chloramphenicol and kanamycin to a final
concentration of 50, 25 and 30 mg/ml respectively, when required) were subcultured
(1:20) in 5 ml of fresh LB broth and growth was monitored by turbidity via optical
density measurement at 600 nm (OD600). Final bacterial cultures were normalized using
OD600 values. Grace’s insect culture medium (Gibco) was used to dilute cultures for
insect injections and dilutional plating.

3.1.2. Construction of the NRPS and ngrA mutant strains
The approach of insertional inactivation of the appropriate genes was utilized to
create the mutant strains. Briefly, for each gene primers were designed to amplify a 200–
800 bp internal fragment located near the 5′ end of the gene. The amplified products were
purified with GeneClean Turbo kit (MP Biomedicals), followed by end conversion and
subsequent blunt end-ligation into the EcoRV site of pSTBlue-1 vector (Novagen).
Several of the resulting recombinant colonies were selected and analyzed by colony PCR
using a T7 and SP6 primer pair from the regions flanking the EcoRV site of pSTBlue-1 to
confirm the size of the cloned fragment. A colony having the desired plasmid was grown
overnight and the plasmids containing the inserts were purified using the QIAprep Spin
Miniprep kit (Qiagen). A PstI–XbaI fragment containing either 2040, 2783, 1763, 2228,
2300, 2467, or 1028 (ngrA) internal gene fragment was gel-purified and ligated into the
conjugal suicide vector pKnock-Cm (30). The resultant recombinant plasmids were
transformed into electrocompetent E. coli S17-λpir and conjugally transferred into the
wild-type strain of X. nematophila. The 2040, 2783, 1763, 2228, 2300, 2467 plasmids
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were also conjugally transferred to the ΔxcnKL strain of X. nematophila to generate
double mutants in the xenocoumacin deletion background strain. Selection on ampicillin
and chloramphenicol identified the mutants in which the recombinant pKnock-Cm had
integrated into the chromosome within the respective gene by single-cross-over
homologous recombination, leading to gene disruption, which was confirmed by PCR.
The primers used in this study are mentioned in TABLE 6.

3.1.3. Antibiotic overlay assay
Six microliter volume of exponential phase subcultures of X. nematophila were
spotted on LB agar plates and incubated. After 24 h of growth, the bacteria were exposed
to chloroform fumes for 30 min followed by air drying for 30 min. Five hundred
microliters of overnight culture of the indicator bacterial strain was added to 6 ml top
agar (LB with 0.7% agar) which was then poured to form an overlay on the X.
nematophila colonies (2, 31). The plates were incubated at 30°C for 48 h. Zones of
inhibition were measured in millimeters. The overlay assays were performed twice, with
nearly identical results.

3.1.4. In vitro competitions in LB and Grace’s
The appropriate X. nematophila strains, E. faecalis and S. saprophyticus
subcultures were set up in either LB or Grace’s medium, depending on the condition
chosen. Cultures were allowed to grow till exponential phase and were normalized based
on O.D.600. The competitions were set up by inoculating (1:20) fresh 5 ml LB or Grace’s

TABLE 6. Primers used in this study
Gene, cluster or vector
ngrA

Cluster A

Cluster B

Cluster C

Cluster D

Cluster E

Cluster F

pKnock
pSTBlue-1

Primer
XN_1028 F
XN_1028 R
XNC1_1028 OF
XNC1_2040 F
XNC1_2040 R
XNC1_2040 OF
XNC1_2783 F
XNC1_2783 R
XNC1_2783 OF
XNC1_1763 F
XNC1_1763 R
XNC1_1763 OF
XNC1_2228 F
XNC1_2228 R
XNC1_2228 OF
XNC1_2300 F
XNC1_2300 R
XNC1_2300 OF
XNC1_2467 F
XNC1_2467 R
XNC1_2467 OF
pKnock-F
pKnock-R
SP6
T7 promoter

Sequence (5'-3')
CATGTCATGCTGGCCTATTTTG
CAAATAGTGTCAGGCCAGATTGG
ACCTCTACTCAAGTCACTAC
TCTCTCAGTACGACTCAGCAAG
CTATCTTGTCTGTAGCGTTGTGAG
TCATGCAATCGTATCAACAACG
GCCAAACGATTAGAAGAAGCTCTC
ACAGTGAATTGTGCAGGATCTTG
TCAAATTGACCCTGACAAACG
CACTTACGGATATGCAGCAGG
GTGTTGTTGCTGCCAATTGAC
TTTGGGAAAACTATTCTGATGTTG
ACAGCATACCGCCAGAATTG
TGAACCTTTAGCACTGGCAAT
TCAATGAGGCGTTAAATCAGGG
CATCATGACAATATACCACCGGAAC
AAGTTCATCCCAATGCTCTGTG
CTTTAAGCCAAGGAGTTACCCTG
GACAGGCTCTCAATGGCAC
GGACTCTGTCACTTTGGTTGATAC
TGCCATAAAAGAGACGCTCCAG
ACACAGGAACACTTAACGGCTGAC
TGCGAAGTGATCTTCCGTCAGAG
ATTTAGGTGACACTATAG
CTAATACGACTCACTATAGGG

Use
Mutant construction
Mutant construction
Mutant screening
Mutant construction
Mutant construction
Mutant screening
Mutant construction
Mutant construction
Mutant screening
Mutant construction
Mutant construction
Mutant screening
Mutant construction
Mutant construction
Mutant screening
Mutant construction
Mutant construction
Mutant screening
Mutant construction
Mutant construction
Mutant screening
Mutant screening
Mutant screening
Mutant screening
Mutant screening
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with 1:1 mixtures of X. nematophila and competitor. The flasks were incubated at 30°C
with shaking and dilution plating using the same medium at 0, 9, 18, 24 h was performed
to obtain CFU/ml of the bacteria. The experiments were performed at least twice,
yielding highly reproducible results.

3.1.5. In vitro competitions in LB with pre-incubated X. nematophila
Overnight cultures of the required X. nematophila strains were subcultured 1:20 in
5 ml of Grace’s and incubated at 30°C for 10-11 h. Subcultures of the competitors E.
faecalis and S. saprophyticus set up in 5 ml Grace’s were allowed to grow till exponential
phase and were normalized based on O.D.600. These were added to the pre-inoculated 1011 h X. nematophila cultures to start the competition. Dilutions were made in Grace’s
medium and plated on LB agar to determine the relative CFU/ml of the different strains
at 0 and 24 h. The experiments were performed twice, with highly similar results.

3.1.6. Antibiotic activity in cell-free supernatants from LB and Grace’s cultures
Overnight cultures of wild-type X. nematophila were subcultured 1:20 in 5 ml of
LB and Grace’s. The cultures were grown at 30°C, shaking, and at 6, 9, 12, 24 h postinoculation 1 ml of cultures were withdrawn from the flasks. This volume was
centrifuged at 14,000 r.p.m for 1.5 min. The cell pellet thus obtained was discarded and
the supernatant was sterilely filtered through 0.2 µm pore size filters (Millipore) attached
to 3 c.c. syringe (B.D.). The sterile supernatants were frozen until used in the antibiotic
assay. The O.D.600. measurement was taken and dilution plating in the respective medium
was also performed at all the timepoints. For the antibiotic assay, 200 µl of a 1:50
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dilution of the overnight culture of S. saprophyticus was used in a 96-well microtitre
plate (BD) to which 20 µl of 1X and 0.5X diluted X. nematophila sterile supernatants
were added. The microtitre plate was incubated at 30°C shaking, and 0 and 24 h O.D. 600
measurements were made to determine the levels of inhibition of S. saprophyticus.

3.1.7. Sources, treatments and rearing of Manduca sexta larvae
M. sexta eggs were obtained from the insect colony at the University of
Wisconsin – Milwaukee. Eggs were placed in clean plastic cups along with diet and
incubated in an insect incubator with at 16:8 h light:dark photoperiod at room
temperature. After hatching, larvae were moved to clean boxes and provided fresh diet.
Boxes were cleaned daily and larvae were fed regularly. The fourth instar stage was used
for all experiments. Commercial premixed diet (North Carolina State University
Insectary, hence referred to as NCSU) without added antibiotics was the diet used,
prepared from individual ingredients. The diet was prepared according to supplier
instructions (32).

3.1.8. In vivo competitions
X. nematophila (ΔxcnKL and ngrA), E. faecalis and S. saprophyticus were
subcultured in LB broth, grown to exponential phase, normalized and diluted in Grace’s
medium. For the competition experiments a 1:1 mixture of 104 CFU/insect of the
appropriate bacterial cultures was prepared in Grace’s medium.. Fifty microliters of the
mixtures were injected per insect using BD 1ml Sub-Q, 0.45 mm x 16 mm syringes
(Becton Dickinson Co.) mounted on a Stepper™ Repetitive Dispensing Pipette (Dymax
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Corp.). Fourth instar M. sexta larvae were anaesthetized by placing on crushed ice for 1520 min and the area around the horn was cleaned using 70% ethanol prior to injection.
Grace’s medium was injected as a negative control. The insects were placed in plastic
cups and hemolymph was collected at designated time points, followed by dilution
plating on LB agar plates. Three to four larvae were used per time point and the
experiment was performed three times, with reproducible results. The experiments were
performed at similar times of the day, with similar feeding cycles for the insects.

3.1.9. Nematode reproduction
Twelve fourth instar M. sexta larvae per strain were used. The larvae were naturally
infected by using S. carpocapsae IJs carrying either the wild-type AN6 or the ngrA strain
of X. nematophila. Briefly, IJs were washed using sterile water. Six larvae were placed on
top of a moistened filter paper in a clean plastic cup. The appropriate volume of the IJ
suspension resulting in 200 IJs/larvae was pipetted in random drops on the filter paper
and the cup was placed in the insect incubator. Following insect death within 48 h, larvae
were transferred to modified White water traps (33) containing 25 ml sterile distilled
water (4 insects per trap). The emerging nematodes were counted in the trap until Day X
after emergence and the average number of IJs per milliliter was determined. Four
independent experiments were conducted, all yielding highly similar results. Data from a
representative experiment is shown.
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3.2. Results
3.2.1. Analysis of NRPS gene clusters for antibiotic activity
We had shown previously that inactivation of the xcnA gene for xenocoumacin
synthesis significantly reduced but did not eliminate antibiotic activity in an overlay
assay using Micrococcus luteus as the indicator strain (8). The residual activity could be a
product of additional NRPS gene clusters. The NRPS gene clusters for the PAX peptides
and rhabdopeptides whose products were shown to possess antifungal and cytotoxic
activity, respectively, had been previously identified (12-14). The genome of X.
nematophila contains four additional NRPS gene clusters, referred to as clusters A, C, E
and F. The compounds synthesized by these clusters have not yet been identified
(TABLE 4). To determine whether the additional gene clusters produced antimicrobial
compounds the first NRPS gene of each cluster was inactivated. We also inactivated the
first NRPS gene in the PAX and the rhabdopeptide clusters In addition, the ngrA gene
that encodes the phosphopantetheinyl transferase required for activity of NRPS and PKS
enzymes was inactivated. The antibiotic activity of the individual mutant strains was
analyzed in an overlay assay using M. luteus as the indicator strain. Antibiotic activity
was not detectably reduced in any of the NRPS mutant strains (data not shown). As
expected, antibiotic production was completely eliminated in the ngrA strain (FIG. 3.2).
Since antimicrobials produced by the NRPS gene clusters may be masked by the high
level of xenocoumacin detected in the overlay assay we created double mutant strains in a
xenocoumacin-deficient background in which xcnK and part of xcnL were deleted
(ΔxcnKL strain). The antibiotic activity of the ΔxcnKL strain was reduced but not
eliminated as shown previously with the xcnA strain (FIG. 3.2). Inactivation of the first
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FIG. 3.2. Antibiotic overlay assay demonstrating activity of xenocoumacin against
M.luteus, E. faecalis and S. saprophyticus; of compound F against M. luteus and S.
saprophyticus; and complete lack of activity of the ngrA mutant. Antibiotic overlay
assays were performed with X. nematophila wild-type and mutant strains (ΔxcnKL,
ΔxcnKL:F, ngrA) against the common indicator organism M. luteus and relevant
competitors isolated from the insect host gut: S. saprophyticus and E. faecalis. The
diameter of the zone of inhibition is proportional to the sensitivity of the competitors to
X. nematophila antibiotics.
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NRPS gene in cluster F in the ΔxcnKL background resulted in almost complete loss of a
zone of inhibition indicating that compound F possessed antibiotic activity against M.
luteus. The ΔxcnKL:C strain also displayed a markedly reduced zone of inhibition
indicating that cluster C also possessed antimicrobial activity (FIG. 3.3). For the other
double mutant strains the zone of inhibition was the same as that for the ΔxcnKL strain
indicating that these clusters did not produce antibiotic activity against M. luteus.
We had previously isolated Staphylococcus saprophyticus and Enterococcus
faecalis strains from the gut of Manduca sexta and showed these microbes translocate
into the hemocoel during nematode invasion (28). In overlay assays, S. saprophyticus
was highly sensitive to X. nematophila antibiotics while E. faecalis was more resistant.
We used these biologically relevant isolates to assess the antibiotic activity of the
ΔxcnKL and ΔxcnKL:F strains. The antibiotic activity of the ΔxcnKL strain was
significantly reduced against S. saprophyticus and was undetectable in the assay against
E. faecalis (FIG. 3.2). Antibiotic activity against S. saprophyticus was further reduced in
the ΔxcnKL:F strain and completely lost in the ngrA strain (FIG. 3.2). These findings
show that xenocoumacin is active against both the biologically relevant competitors S.
saprophyticus and E. faecalis, and it is the major antibiotic activity against E. faecalis.
Compound F was shown to possess activity against S. saprophyticus. The ΔxcnKL, F,
ΔxcnKL:F, and ngrA mutant strains were used for further analysis.

3.2.2. Competition of S. saprophyticus and E. faecalis with X. nematophila
The above results suggested that xenocoumacin and compound F are active
against microbial competitors that enter the hemocoel during early stage infection. Since

FIG. 3.3. Antibiotic overlay assay demonstrating antibiotic activity of compound C and lack of activity of compounds A, B, D
and E. Antibiotic overlay assays were performed with X. nematophila wild-type and mutant strains (ΔxcnKL, ΔxcnKL:A, ΔxcnKL:B,
ΔxcnKL:C, ΔxcnKL:D, ΔxcnKL:E) against the common indicator organism M. luteus. The diameter of the zone of inhibition is
proportional to the sensitivity of the competitors to X. nematophila antibiotics.
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xenocoumacin has been shown to be produced in nutrient-rich medium (LB broth),
competition experiments were first performed between wild-type and mutant strains of X.
nematophila and either S. saprophyticus or E. faecalis in LB broth (FIGS. 3.4 and 3.5).
Exponentially growing X. nematophila and competitor cultures were co-inoculated in a
1:1 ratio and grown for 24 h. Culture samples were dilutionally plated at 9 h, 18 h and 24
h to determine the relative cell density of the respective strains. By 9 h the cell density of
the X. nematophila strains and S. saprophyticus had increased over 100-fold (FIG. 3.4).
The ratio of S. saprophyticus to X. nematophila was higher in the ΔxcnKL, ΔxcnKL:F and
ngrA co-cultures. At 18 h the cell density of S. saprophyticus was significantly reduced in
co-cultures with the wild-type and F strain, while the S. saprophyticus was eliminated by
24 h. In contrast, the levels of S. saprophyticus remained high at 24 h in co-cultures with
the ΔxcnKL and ΔxcnKL:F strains and was significantly higher in the ngrA strain. These
results indicated that xenocoumacin but not compound F was required to eliminate S.
saprophyticus in LB broth co-cultures.
Co-culture competition experiments were also carried out with E. faecalis (FIG.
3.5). At 9 h the cell density of all X. nematophila strains except the ngrA strain was
higher than the level of E. faecalis. At 18 h and 24 h E. faecalis was eliminated in all cocultures except for those with the ngrA strain. These findings indicate that neither
xenocoumacin nor compound F were required to eliminate E. faecalis, and that other
NRPS-derived compounds were active against this competitor.
To more closely mimic the biological conditions that occur during natural
infection, competition experiments were performed in Grace’s medium, a defined
medium based on lepidopteran hemolymph (FIG. 3.6). In co-cultures with S.

FIG. 3.4. In vitro competition between X. nematophila mutant strains and S. saprophyticus in LB. Subcultures of X. nematophila
wild-type and mutant strains (ΔxcnKL, F, ΔxcnKL:F, ngrA) (dark gray bars) were mixed in a 1:1 ratio with S. saprophyticus (white
hatched bars) and then used to inoculate fresh LB broth. Competition outcome was determined by dilution plating 0 (A), 9 (B), 18 (C),
and 24 h (D). Graphs depict colony forming units/ml (CFU/ml) of both bacteria. Asterisks depict statistically significant differences
(P<0.05) as calculated by multiple paired t-tests using GraphPad Prism 6.
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FIG. 3.5. In vitro competition between X. nematophila mutant strains and E. faecalis in LB. Subcultures of X. nematophila wildtype and mutant strains (ΔxcnKL, F, ΔxcnKL:F, ngrA) (dark gray bars) were mixed in a 1:1 ratio with E. faecalis (light gray bars) and
then used to inoculate fresh LB broth. Competition outcome was determined by dilution plating at 0 (A), 9 (B), 18 (C), and 24 h (D).
Graphs depict colony forming units/ml (CFU/ml) of both bacteria. Asterisks depict statistically significant differences (P<0.05) as
calculated by multiple paired t-tests using GraphPad Prism 6.
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FIG. 3.6. In vitro competition of wild-type X. nematophila with S. saprophyticus (A)
or E. faecalis (B) in Grace’s. Subcultures of wild-type X. nematophila were mixed in a
1:1 ratio with either S. saprophyticus (white hatched bars) or E. faecalis (light gray bars)
and then used to inoculate fresh Grace’s media. Competition outcome was determined by
dilution plating at times 0, 9, 24, and 48 h. Graphs depict colony forming units/ml
(CFU/ml) of both bacteria. No statistically significant differences between X.
nematophila and the competitors were found at any of the time points.
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saprophyticus the cell density of wild-type X. nematophila at 9 h was ~5.8x108 CFU/ml,
in contrast to the ~10-fold higher level that was reached in LB broth. Unlike in the cocultures in LB broth the cell density of S. saprophyticus was actually higher than X.
nematophila at 24 h and remained at high levels at 48 h (FIG. 3.6.A). The same results
were obtained in co-cultures with E. faecalis (FIG. 3.6.B). Thus, in Grace’s medium the
cell density of wild-type X. nematophila was ~10-fold less than the level reached in LB
broth and the amount of antimicrobials produced were not sufficient to eliminate either S.
saprophyticus or E. faecalis. In addition, we found that when grown individually both S.
saprophyticus and E. faecalis grew much faster than X. nematophila in Grace’s medium
during early growth phase. At 6 h the cell density of S. saprophyticus and E. faecalis was
~ 8-fold and 105-fold greater, respectively, than X. nematophila (TABLES 7 and 8).

3.2.3. Comparison of antibiotic activity in LB broth and Grace’s medium culture
supernatants
To compare the relative levels of antibiotic activity produced by wild-type X.
nematophila grown in LB broth and Grace’s medium, sterile cell-free supernatants
prepared from cultures grown for 6 h, 9 h and 12 h were assayed in a microplate format
using S. saprophyticus as the indicator strain (TABLE 9). Results were expressed as %
inhibition of growth comparing the cell density (measured as optical density, O.D600) of
the treated culture with the untreated culture of S. saprophyticus. At 6 h antibiotic activity
was detectable at low and variable levels with either LB broth or Grace’s medium
supernatants.

At 9 h the undiluted LB broth supernatants displayed 90% growth

inhibition while the 0.5X diluted sample gave 34% growth inhibition. At 12 h the

TABLE 7. Growth comparison between X. nematophila and S. saprophyticus in Grace’s medium
X. nematophila

a

Time (h)

CFU/ml x 108

0
6
9
12
24

0.12 (0.01)
2.88 (0.50)
19.65 (2.69)
15.87 (4.03)
9.28 (0.48)

S. saprophyticus

S. sapro/X. nem

Fold increase a

CFU/ml x 108

Fold increase a

Fold increase

24.00
163.75
132.25
77.33

0.28 (0.01)
53.70 (11.29)
93.90 (23.74)
59.13 (11.14)
23.35 (2.65)

191.79
335.36
211.18
83.39

7.99
2.05
1.60
1.08

CFU/ml relative to that at 0 h
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TABLE 8. Growth comparison between X. nematophila and E. faecalis in Grace’s medium
X. nematophila

a

E. faecalis

E. faec/X. nem

Time (h)

CFU/ml x 107

Fold increase a

CFU/ml x 108

Fold increase a

Fold increase

0
6
9
12
24

0.11 (0.03)
7.10 (1.35)
78.43 (13.95)
87.70 (6.82)
53.38 (12.75)

64.55
713.00
797.27
485.27

0.11 (0.02)
746.25 (136.55)
1291.93 (598.31)
543.13(90.22)
30.90 (3.17)

6784.09
11744.82
4937.55
280.91

105.10
16.47
6.19
0.58

CFU/ml relative to that at 0 h
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TABLE 9. X. nematophila antibiotic activity in cell-free supernatants
Time (h)

% Inhibition

LB broth

6
9
12

1X
10.3 (3.7)
89.9 (3.8)
96.3 (0.7)

0.5X
8.4 (3.3)
33.5 (2.2)
84.0 (2.3)

Grace’s medium

6
9
12

10.2 (1.3)
20.1 (0.6)
96.9 (0.6)

14.1 (1.1)
7.8 (3.7)
4.2 (2.2)
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antibiotic activity had increased in the LB broth supernatants, and was present at high
levels in both undiluted and diluted supernatants. In contrast, the antibiotic activity in the
supernatant from Grace’s medium was barely detectable at 9 h. At 12 h the undiluted
supernatants from Grace’s medium displayed

~ 97% growth inhibition while little

activity was present in the diluted supernatants. The low level of production in Grace’s
medium correlated with lower cell density relative to the LB broth levels (FIG. 3.7).
These findings show that antibiotics were produced later and at lower levels in Grace’s
medium as compared to LB broth cultures.

3.2.4. Competition in Grace’s medium pre-inocubated with X. nematophila strains
The combination of low level antibiotic production by X. nematophila and more
rapid initial growth rates of S. saprophyticus and E. faecalis in Grace’s medium resulted
in the inability of X. nematophila to suppress growth of microbial competitors. To further
assess the role of antimicrobial production in interspecies competition, wild-type and
mutant strains of X. nematophila were first inoculated in Grace’s medium and grown for
10.5 or 11.5 h before inoculating with either S. saprophyticus or E. faecalis. The cocultures were dilutionally plated at 24 h to determine the cell density of the respective
strains (TABLES 10 and 11). S. saprophyticus was eliminated in co-cultures with the
wild-type and NRPS mutant strains but grew to high levels in co-culture with the ngrA
strain. These findings indicate that NRPS-derived antibiotics other than xenocoumacin
and compound F were required to eliminate S. saprophyticus in Grace’s medium. In
contrast, E. faecalis was not eliminated when co-cultured with any of the pre-inoculated
X. nematophila strains. The relative resistance of E. faecalis to X. nematophila antibiotics
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FIG. 3.7. Temporal cell density of X. nematophila in LB broth and Grace’s medium

TABLE 10. Competition of S. saprophyticus with pre-incubated X. nematophila in Grace’s medium

Strains
WT
ΔxcnKL
F
ΔxcnKL:F
ngrA

X. nematophila
Initial cell density a
CFU/ml x 108 b
25.5 (3.0)
21.7 (2.1)
31.9 (4.4)
32.7 (3.2)
34.9 (4.7)

S. saprophyticus
CFU/ml x 108
1.1 (0.1)
1.1 (0.1)
1.1 (0.1)
1.1 (0.1)
1.1 (0.1)

Cell density after 24 h c
WT
ΔxcnKL
F
ΔxcnKL:F
ngrA

7.9 (1.7)
3.9 (0.8)
3.9 (0.4)
1.4 (0.3)
6.9 (0.9)

0.0
0.0
0.0
0.0
3.8 (0.6)

a

Cell density at start of competition after X. nematophila was pre-incubated for 10.5 h
Values represent mean and standard error (parentheses)
c
Cell density after 24 h of competition

b
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TABLE 11. Competition of E. faecalis with pre-incubated X. nematophila in Grace’s medium

Strains
WT
ΔxcnKL
F
ΔxcnKL:F
ngrA

X. nematophila
Initial cell density a
CFU/ml x 108 b
14.3 (1.2)
13.9 (1.4)
45.5 (5.3)
26.4 (2.2)
31.6 (2.8)

E. faecalis
CFU/ml x 108
0.7 (0.0)
0.7 (0.0)
0.7 (0.0)
0.7 (0.0)
0.7 (0.0)

Cell density after 24 h c
WT
ΔxcnKL
F
ΔxcnKL:F
ngrA

9.1 (0.9)
5.6 (0.4)
19.3 (1.3)
3.0 (0.5)
18.7 (2.8)

0.7 (0.3)
0.1 (0.0)
0.9 (0.1)
0.4 (0.0)
2.1 (0.4)

a

Cell density at start of competition after X. nematophila was pre-incubated for 11.5 h
Values represent mean and standard error (parentheses)
c
Cell density after 24 h of competition
b
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and the lower level of antibiotic production by X. nematophila in Grace’s medium
apparently accounts for the inability to eliminate this competitor.

3.2.5. Competition in the insect host, Manduca sexta
We had previously shown that when S. saprophyticus was injected into M. sexta it
was present in the hemolymph at low levels (~102 CFU/ml) at 9 h and grew to slightly
higher cell density (~103 CFU/ml) at 24 h (28). However, when S. saprophyticus was coinjected with wild-type X. nematophila it was eliminated by 24 h. This finding, together
with the sensitivity of S. saprophyticus to X. nematophila antibiotics, suggested that
antibiotic production could be involved in the elimination of S. saprophyticus in vivo. To
address this question S. saprophyticus was co-injected into the hemocoel of M. sexta with
either the ΔxcnKL (FIG. 3.8) or the ngrA strain (FIG. 3.9) and hemolymph was collected
and dilutionally plated at 8 h and 24 h post-injection. In both cases S. saprophyticus was
present at 8 h and was eliminated by 24 h. This finding suggests that NRPS-derived
antibiotics were not essential for elimination of S. saprophyticus in vivo. In contrast, E.
faecalis growth was shown to be facilitated when co-injected with wild-type X.
nematophila (28) and also was facilitated when co-injected with either the ΔxcnKL (FIG.
3.8) or ngrA (FIG. 3.9) strain.

3.2.6. Natural infection and nematode reproduction in M. sexta
It has been proposed that sub-inhibitory concentrations of antibiotics and other
secondary metabolites can function as signaling molecules (22-24, 34, 35). With this in
mind we addressed the possibility that NRPS-derived compounds produced by X.
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FIG. 3.8. In vivo growth after 1:1 co-injections of X. nematophila ΔxcnKL strain with
S. saprophyticus or E. faecalis into M. sexta. Insects were co-injected with a 1:1 mixture
of X. nematophila ΔxcnKL (dark gray bars) with either S. saprophyticus (white hatched
bars) or E. faecalis (light gray bars). 104 CFU/insect of each strain were injected.
Hemolymph recovered at 8 and 24 h post-injection was dilutionally plated. Data are
represented as CFU/ml of each bacterial species at 8 and 24 h. Asterisks depict
statistically significant differences (P<0.05) as calculated by multiple paired t-tests using
GraphPad Prism 6.
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FIG. 3.9. In vivo growth after 1:1 co-injections of X. nematophila ngrA strain with S.
saprophyticus or E. faecalis into M. sexta. Insects were co-injected with a 1:1 mixture
of X. nematophila ngrA (dark gray bars) with either S. saprophyticus (white hatched bars)
or E. faecalis (light gray bars). 104 CFU/insect of each strain were injected. Hemolymph
recovered at 8 and 24 h post-injection was dilutionally plated. Data are represented as
CFU/ml of each bacterial species at 8 and 24 h. Asterisks depict statistically significant
differences (P<0.05) as calculated by multiple paired t-tests using GraphPad Prism 6.
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nematophila might play a role in in vivo reproduction of the nematode, S. carpocapsae.
To assess this possibility, IJs harboring either the wild-type or ngrA strain of X.
nematophila were used for natural infections of M. sexta. When the insects died 24-48 h
post-injection the cadavers were transferred to water traps and the cumulative number of
emergent progeny IJs was monitored over a 27 day period (FIG. 3.10). When infected
with wild-type X. nematophila - carrying nematodes, progeny IJs began to appear in the
water traps at day 11 and continued to accumulate for 25 days reaching a level of 7300
IJs/ml. In contrast, when infected with IJs colonized with the ngrA strain, progeny IJs
appeared in much lower numbers and after 25 days only 1947 IJs/ml had accumulated in
the water traps. In contrast, nematodes reproduced to a similar extent on lawns of wild
type and ngrA strains (data not shown) suggesting that the ngrA strain was not defective
in providing a nutrient base for nematode reproduction. The ngrA strain also grew as well
as the wild type strain when injected into M. sexta (FIG. 3.9). Together, these findings
suggest that NRPS-derived compounds are involved in stimulating optimal nematode
reproduction and emergence in vivo.
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FIG. 3.10. In vivo nematode reproduction using S. carpocapsae carrying X.
nematophila wild-type and ngrA strains after natural infection of M. sexta. The total
number of IJs emerging from insect cadavers infected with S. sarpocasae harboring
either wild-type (dark gray bars) or ngrA (light gray bars) X. nematophila strains were
counted for a period of 27 days from the day of trapping. Three traps containing four
insects each were used for both sets and IJs were counted in five 5 µl drops (n = 15).
Except for the initial time point (Day 11), the mean values for the wild type and the
mutant were significantly different at each time point (two-tailed P<0.01); when paired at
each time point (including Day 11), the wild type and the mutant were also significantly
different over the entire time scale examined (paired two-tailed P<0.001). Error bars
represent standard errors.
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3.3. Discussion
We showed previously that insect gut microbes translocate into the hemocoel
during nematode invasion. Transient species such as S. saprophyticus disappeared early
while persistent species such as E. faecalis proliferated in the presence of X. nematophila.
In the present study we examined the possible role of NRPS-derived antimicrobials in
early stages of interspecies competition. X. nematophila possesses seven NRPScontaining gene clusters and two large stand alone NRPS genes. Transfer of a
phosphopantetheinyl group to the PCP domain by PPant transferase encoded by ngrA is
required for NRPS function. Using NRPS and ngrA mutant strains and an overlay
diffusion assay we found that xenocoumacin and an uncharacterized antimicrobial,
compound F, accounted for most of the antimicrobial activity against S. saprophyticus.
Xenocoumacin, a hydrophilic benzopyran compound, was shown previously to be active
against S. aureus and Streptococcus species (7). The present study is the first to show that
xenocoumacin is active against a potential competitor derived from the gut of an insect
host. As predicted from previous results E. faecalis was relatively resistant to X.
nematophila antibiotics.
Most of the X. nematophila antimicrobials and secondary metabolites
characterized to date are hydrophobic. Since the overlay assay detects compounds that
diffuse away from a bacterial colony grown on LB agar more hydrophobic compounds
may exhibit limited activity in this assay. For this reason a liquid medium-based
competition assay in which antibiotics disperse throughout the culture was used to
examine the role of NRPS-derived compounds in interspecies competition. Wild-type and
NRPS mutant strains were co-inoculated in LB broth with either S. saprophyticus or E.
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faecalis and cultures were continually shaken during the assay. S. saprophyticus was not
eliminated in co-cultures with either the ΔxcnKL or ΔxcnKL:F strains but was eliminated
in co-cultures with the wild-type and F strains indicating that

xenocoumacin was

required to eliminate S. saprophyticus. In contrast, E. faecalis was eliminated in cocultures with the ΔxcnKL and ΔxcnKL:F strains but not the ngrA strain indicating that
NRPS-derived antibiotics other than xenocoumacin and compound F were produced at
levels sufficient to eliminate E. faecalis.
To assess the contribution of antimicrobials under more natural biological
conditions co-culture competition experiments were performed in Grace’s insect medium.
Under these conditions neither S. saprophyticus nor E. faecalis were eliminated
suggesting that antimicrobials were produced at sub-inhibitory levels. Indeed, antibiotic
activity in sterile cell-free supernatants from X. nematophila grown in Grace’s medium
was markedly lower than supernatants for cells grown in LB broth. Importantly, the cell
density of the Grace’s medium cultures was ~10-fold lower than in LB broth. In many
microbial species studied robust antibiotic production involves quorum sensing in which
accumulation of autoinducer molecules at higher cell densities activate the expression of
secondary metabolite genes (22). The lower cell density and autoinducer concentrations
in cultures in Grace’s medium could result in reduced levels of antibiotic production and
the inability to eliminate competitors. In addition, secondary metabolite production was
induced by the addition of 50 mM L-proline to cultures of X. nematophila (36). Grace’s
medium contains only 3 mM L-proline. We found that addition of 50mM L-proline to
Grace’s cultures did not stimulate antibiotic production (unpublished data) suggesting
that other environmental and metabolic signals may be involved in inducing NRPS genes
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in X. nematophila in Grace’s medium. In well studied antibiotic producers such as
Streptomyces coelicolor numerous regulatory cascades and metabolic signals control
antibiotic production (37). Taken together, the lower cell density of X. nematophila and
possible suboptimal inducing conditions could account for the inability to eliminate
competitors in Grace’s medium.
We also found that the cell density of S. saprophyticus in Grace’s medium
increased 8-fold faster than X. nematophila at 6 h post-inoculation. Thus, competitor cell
densities reached high levels before antibiotics have time to accumulate. To be able to
detect antimicrobial activity in Grace’s medium X. nematophila was first grown for ~10 h
and S. saprophyticus was subsequently inoculated into the culture. Under these
conditions S. saprophyticus was eliminated by the wild-type and NRPS strains but not the
ngrA strain indicating that NRPS-derived antimicrobial besides xenocoumacin and
compound F were able to inhibit growth of S. saprophyticus. Thus, detection of
antimicrobial activity against S. saprophyticus was dependent on the type of assay
employed.

Xenocoumacin and compound F were detected in the overlay assay,

xenocoumacin but not compound F in the LB competition assay and NRPS-derived
antimicrobial activity besides xenocoumacin and compound F in the Grace’s medium
assay. Elucidation of the environmental and metabolic signals that control NRPS gene
expression would shed light on the role of antimicrobial activity in interspecies
competition in different host insects.
We showed previously that S. saprophyticus persisted when injected alone into M.
sexta, proliferated when co-injected with E. faecalis and was eliminated when co-injected
with X. nematophila. Here we show that co-injection with either the ΔxcnKL or ngrA
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strains resulted in disappearance of S. saprophyticus. Thus, antimicrobial agents other
than NRPS-derived compounds may be involved in the elimination of S. saprophyticus
and presumably other transient species. X. nematophila produces indole derived
compounds that are highly active against B. cereus and M. luteus (20), nematophin that is
active against S. aureus strains (21) and benzylideneacetone that possesses both
antimicrobial and immunosuppressive activities and is active against Gram-negative plant
pathogens (18).

X. nematophila may also produce additional as yet unidentified

compounds that are active against transient species. Since gut microbiota may vary
widely in different insect hosts the potential to synthesize a spectrum of antimicrobial
compounds that are active against a variety of microbes confers competitive advantages
in diverse host environments.
It remains unknown whether during early stages of infection X. nematophila
produces antimicrobials at levels that can inhibit species growing in the hemolymph of
M. sexta. Using an in-vivo expression technology approach NRPS genes encoding
rhabdopeptide that possesses anti-parasite activity were shown to be expressed soon after
X. nematophila was injected into M. sexta (14). Induction of other NRPS genes that
encode known antimicrobial compounds was not detected by this approach. As discussed
above, L-proline induces secondary metabolite synthesis in X. nematophila (36). The Lproline concentration in M. sexta is low (3 mM) relative to that in other lepidopterans
such as Galleria mellonella (72 mM). Furthermore, X. nematophila was barely detectable
at early stages of natural infection unlike the higher levels present when co-injected with
S. saprophyticus (FIGS. 3.8 and 3.9). Thus, elimination of transient species during early
stages of natural infection may be due initially to activation of immune responses. As X.
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nematophila proliferates with concomitant suppression of immune responses increased
antimicrobial levels could effectively inhibit growth of transient competitors.
Presumably, when X. nematophila reaches higher cell density during later stages of
infection elevated levels of antimicrobials prevent the reemergence of transient species.
The scenario for interactions between X. nematophila and a persistent species
such as E. faecalis is distinctly different. E. faecalis is relatively resistant to
xenocoumacin but is sensitive to other yet identified antimicrobials produced by X.
nematophila grown in LB broth. In contrast, antimicrobial activity produced in Grace’s
medium was insufficient to eliminate E. faecalis. In addition, the increase in cell density
of E. faecalis inoculated into Grace’s was 105-fold greater than X. nematophila 6 h postinoculation. Furthermore, rather than being eliminated, E. faecalis growth was facilitated
by the presence of X. nematophila in vivo. We had shown that E. faecalis strongly
induced cecropin transcription in M. sexta while transcript levels were reduced markedly
when E. faecalis was co-injected with X. nematophila. Together, these findings suggest
that the dominance and persistence of E. faecalis during natural infection could result
from the combination of rapid growth rate after translocation into the insect hemolymph,
relative resistance to antimicrobials produced in the hemolymph and suppression of the
host immune response by X. nematophila.
Bacterial factors that influence S. carpocapsae growth and development in vivo
had not been previously studied. Here we show that reproduction of nematodes in M.
sexta naturally infected with IJs colonized with the ngrA strain was dramatically reduced
relative to levels obtained with the wild-type strain.

It was shown previously that

nematodes reared on lawns of an lrp strain in which numerous phenotypic traits were lost
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reproduced to a lesser extent than those raised on the wild-type lawns (38). The number
of IJ progeny that emerged from the lrp lawns was ~85% of the number obtained with the
wild-type strain. In P. luminescens inactivation of ngrA resulted in loss of antibiotic and
siderophore production while other phenotypic traits examined were similar to the wildtype strain (27). The development of Heterorhabditis bacteriophora IJs to the J4 stage
was significantly reduced when grown on lawns of the ngrA strain. Moreover, nematodes
were unable to reproduce on the ngrA strain. Since a siderophore mutant was able to
support nematode reproduction (39) it was concluded that the ngrA gene is involved in
production of a signaling compound for nematode development. Likewise, recovery of H.
bacteriophora IJs on a P. luminescens strain that was deficient in production of
multipotent stilbene compounds was significantly reduced relative to that of nematodes
grown on lawns of wild-type cells (40). Thus, in P. luminescens both ngrA-derived
compounds and stilbenes are required for nematode reproduction in vitro. Whether these
compounds are involved in growth and development in vivo remains to be determined. To
our knowledge the findings of the present study with the ngrA strain are the first to
establish a role for bacterial products for S. carpocapsae growth and development in an
insect host.
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Appendix
Supplemental Figures: Structures of Compounds Produced by X.
nematophila and Schematic Illustrations of NRPSs
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FIG. A.1. Known antimicrobial compounds produced by X. nematophila. (Sources:
Xenocoumacin - McInerney BV, Taylor WC, Lacey MJ, Akhurst RJ, Gregson RP. 1991.
Biologically active metabolites from Xenorhabdus spp., Part 2. Benzopyran-1-one
derivatives with gastroprotective activity. J. Nat. Prod. 54:785-795; xenematide and
xenortide - Lang G, Kalvelage T, Peters A, Wiese J, Imhoff JF. 2008. Linear and cyclic
peptides from the entomopathogenic bacterium Xenorhabdus nematophilus. J. Nat. Prod.
71:1074-1077; PAX - Fuchs SW, Proschak A, Jaskolla TW, Karas M, Bode HB. 2011.
Structure elucidation and biosynthesis of lysine-rich cyclic peptides in Xenorhabdus
nematophila. Org. Biomol. Chem. 9:3130-3132; rhabdopeptide - Reimer D, Cowles
KN, Proschak A, Nollmann FI, Dowling AJ, Kaiser M, Constant Rf, Goodrich-Blair H,
Bode HB. 2013. Rhabdopeptides as insect-specific virulence factors from
entomopathogenic bacteria. Chembiochem. 14:1991-1997)
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FIG. A.2. Other small molecules produced by X. nematophila with antibiotic
activity. (Sources: Indole derivatives – Paul VJ, Frautschy S, Fenical W, Nealson KH.
1981. Antibiotics in microbial ecology, isolation and structure assignment of several new
antibacterial compounds from the insect-symbiotic bacteria Xenorhabdus spp. J. Chem.
Ecol. 7:589-597 and Sundar L, Chang FN. 1993. Antimicrobial activity and biosynthesis
of indole antibiotics produced by Xenorhabdus nematophilus. J. Gen. Microbiol.
139:3139-3148; nematophin - Li J, Chen G, Webster JM. 1997. Nematophin, a novel
antimicrobial substance produced by Xenorhabdus nematophilus (Enterobactereaceae).
Can. J. Microbiol. 43:770-773; benzylideneacetone - Ji D, Yi Y, Kang GH, Choi YH,
Kim P, Baek NI, Kim Y. 2004. Identification of an antibacterial compound,
benzylideneacetone, from Xenorhabdus nematophila against major plant-pathogenic
bacteria. FEMS Microbiol. Lett. 239:241-248)
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FIG. A.3. Reactions catalyzed by NRPS domains. (A) The A domain recognizes and
activates a dedicated amino acid, (B) the activated aminoacyl adenylate covalently
attaches onto the free thiol group of the PCP-bound Ppant cofactor, (C) the C domain
carries out peptide elongation by catalyzing an attack of the nucleophilic amine of the
acceptor substrate onto the electrophilic thioester of the donor substrate. (Source: Sieber
SA, Marahiel MA. 2005. Molecular mechanisms underlying nonribosomal peptide
synthesis: approaches to new antibiotics. Chem. Rev. 105:715-738)
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FIG. A.4. Phosphopantetheinylation by the enzyme PPTase which is a product of
the ngrA gene in X. nematophila. The phosphopantetheine moiety of coenzyme A is
covalently attached to the PCP domain by PPTase, a dedicated phosphopantetheinyl
transferase. (Adapted from: Sieber SA, Marahiel MA. 2005. Molecular mechanisms
underlying nonribosomal peptide synthesis: approaches to new antibiotics. Chem. Rev.
105:715-738)
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